2020


  1. Pelz JO, Weinreich A, Schob S, Saur D (2020). Multiparametric 3D Contrast-Enhanced Ultrasound to Assess Internal Carotid Artery Stenosis: A Pilot Study. J Neuroimaging, 30, 82-89.
     


  2. 2019


  3. Weise CM, Bachmann T, Schroeter ML, Saur D (2019). When less is more: Structural correlates of core executive functions in young adults - A VBM and cortical thickness study. Neuroimage, 189, 896-903.
     
  4. Klingbeil J, Wawrzyniak M, Stockert A, Karnath HO, Saur D (2019). Hippocampal diaschisis contributes to anosognosia for hemiplegia: Evidence from lesion network-symptom-mapping. Neuroimage, 208, 116485.
     
  5. Michalski D, Jungk C, Brenner T, Dietrich M, Nusshag C, Weigand MA, Reuss CJ, Beynon C, Bernhard M (2019). [Neurological intensive care medicine : Intensive medical care studies from 2018-2019]. Anaesthesist, 68, 1.
     
  6. Mages B, Aleithe S, Blietz A, Krueger M, Hartig W, Michalski D (2019). Simultaneous alterations of oligodendrocyte-specific CNP, astrocyte-specific AQP4 and neuronal NF-L demarcate ischemic tissue after experimental stroke in mice. Neurosci Lett, 711, 134405.
     
  7. Aleithe S, Blietz A, Mages B, Hobusch C, Hartig W, Michalski D (2019). Transcriptional Response and Morphological Features of the Neurovascular Unit and Associated Extracellular Matrix After Experimental Stroke in Mice. Mol Neurobiol, 56, 7631-7650.
     
  8. Krueger M, Mages B, Hobusch C, Michalski D (2019). Endothelial edema precedes blood-brain barrier breakdown in early time points after experimental focal cerebral ischemia. Acta Neuropathol Commun, 7, 17-.
     
  9. Rumpf JJ, Barbu A, Fricke C, Wegscheider M, Classen J (2019). Posttraining Alpha Transcranial Alternating Current Stimulation Impairs Motor Consolidation in Elderly People. Neural Plast, 2019, 2689790-.
     
  10. Rumpf JJ, May L, Fricke C, Classen J, Hartwigsen G (2019). Interleaving Motor Sequence Training With High-Frequency Repetitive Transcranial Magnetic Stimulation Facilitates Consolidation. Cereb Cortex, 29, 1.
     
  11. Wartenberg KE, Hwang DY, Haeusler KG, Muehlschlegel S, Sakowitz OW, Madzar D, Hamer HM, Rabinstein AA, Greer DM, Hemphill JC 3rd, Meixensberger J, Varelas PN (2019). Correction to: Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society. Neurocrit Care, 31(3), 596-.
     
  12. Wartenberg KE, Hwang DY, Haeusler KG, Muehlschlegel S, Sakowitz OW, Madzar D, Hamer HM, Rabinstein AA, Greer DM, Hemphill JC 3rd, Meixensberger J, Varelas PN (2019). Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society. Neurocrit Care, 31, 231-244.
     
  13. Baum P, Nowicki M, Toyka KV, Kosacka J (2019). Pathophysiologie der diabetischen Neuropathie (DN), Rolle von Entzündung und Eisenstoffwechsel Diabetologe, 15, 1.
     
  14. Karlas T, Blank V, Pelz JO (2019). A Standardized Metrical 3D Ultrasound Approach for Limb Examination. Ultraschall Med, 40(4), 513-514.
     
  15. Pelz JO, Belau E, Menze I, Woost TB, Classen J, Weise D (2019). Correlation between sonographic morphology and function of the cervical vagus nerves. Auton Neurosci, 220, 102552.
     
  16. Pelz JO, Fischer MM, Bungert-Kahl P, Lindner D, Fricke C, Michalski D (2019). Fluid Balance Variations During the Early Phase of Large Hemispheric Stroke Are Associated With Patients' Functional Outcome. Front Neurol, 10, 720-.
     
  17. Fricke C, Duesmann C, Woost TB, von Hofen-Hohloch J, Rumpf JJ, Weise D, Classen J (2019). Dual-Site Transcranial Magnetic Stimulation for the Treatment of Parkinson's Disease. Front Neurol, 10, 174.
     
  18. Fricke C, Gentner R, Alizadeh J, Classen J (2019). Linking Individual Movements to a Skilled Repertoire: Fast Modulation of Motor Synergies by Repetition of Stereotyped Movements. Cereb Cortex, 28, 1.
     
  19. Weise CM, Bachmann T, Pleger B (2019). Brain structural differences in monozygotic twins discordant for body mass index. Neuroimage, 201, 116006-.
     
  20. Stoppe M, Meyer K, Schlingmann M, Olbrich S, Then Bergh F (2019). Hyperstable arousal regulation in multiple sclerosis. Psychoneuroendocrinology, 110, 104417-.
     
  21. Weise D, Pargac C, Pelz JO, Rumpf JJ, Fricke C, Classen J (2019). Assessing blink reflex circuits by three different afferent routes in Parkinson's disease. Clin Neurophysiol, 130(4), 582-587.
     
  22. Pelz J, Weise D (2019). Sonographie des N. vagus - Methodik und Indikation Neurophysiol Lab, 41, 91-98.
     
  23. Fischer M, Kohler W, Faiss JH, Hoffmann F, Kunkel A, Sailer M, Schwab M, Zettl UK, Bublak P (2019). A smart peek: Processing of rapid visual displays is disturbed in newly diagnosed, cognitively intact MS patients and refers to cognitive performance and disease progression in late stages. J Neurol Sci, 401, 118-124.
     
  24. Köhler W, Bien C, Ehrlich S, Faiss J, Finke C, Gold R, Günther A, Harms L, Heigl F, Heine J, Hoffmann F, Janzen RWC, Jungehülsing GJ, Kieseier B, Kleitner I, Kraft A, Paul F, Prüß H, Schimrigk S, Sommer C, Stettner M, Trebst C, Tumani H (2019). Konsensuspapier zum Einsatz der therapeutischen Apherese in der Neurologie DGNeurologie, 2, 15-33.
     
  25. Kohlert K, Jahne K, Saur D, Meixensberger J (2019). Neurophysiological examination combined with functional intraoperative navigation using TMS in patients with brain tumor near the central region-a pilot study. Acta Neurochir (Wien), 161(9), 1853-1864.
     
  26. Reuss CJ, Dietrich M, Beynon C, Hecker A, Jungk C, Michalski D, Nusshag C, Schmidt K, Bernhard M, Brenner T, Weigand MA (2019). [Fluid therapy : Intensive care studies from 2018-2019]. Anaesthesist, 68, 697-701.
     
  27. Dietrich M, Reuss CJ, Beynon C, Hecker A, Jungk C, Michalski D, Nusshag C, Schmidt K, Bernhard M, Brenner T, Weigand MA (2019). [Ventilation and oxygen therapy : Intensive care studies from 2018-2019]. Anaesthesist, 68, 770-776.
     
  28. Nusshag C, Beynon C, Dietrich M, Hecker A, Jungk C, Michalski D, Schmidt K, Weigand MA, Reuss CJ, Bernhard M, Brenner T (2019). [Focus on nephrology : Intensive medical care studies from 2018-2019]. Anaesthesist, 68, 854-858.
     
  29. Schoniger S, Schutze E, Michalski D, Puchta J, Kaiser M, Hartig W (2019). Neuropathological findings suggestive for a stroke in an alpaca (Vicugna pacos). Acta Vet Scand, 61(1), 1.
     
  30. Kosacka J, Woidt K, Toyka KV, Paeschke S, Kloting N, Bechmann I, Bluher M, Thiery J, Ossmann S, Baum P, Nowicki M (2019). The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice. Neurol Res, 41(4), 341-353.
     
  31. Paeschke S, Baum P, Toyka KV, Bluher M, Koj S, Kloting N, Bechmann I, Thiery J, Kosacka J, Nowicki M (2019). The Role of Iron and Nerve Inflammation in Diabetes Mellitus Type 2-Induced Peripheral Neuropathy. Neuroscience, 406, 496-509.
     
  32. Krasselt M, Schober R, Weis J, Baum P, Baerwald CGO, Seifert O (2019). A Primary Myopathy Complicating Long-lasting Polymyalgia Rheumatica. J Clin Rheumatol, 25, 1.
     
  33. Petroff D, Czerny M, Kolbel T, Melissano G, Lonn L, Haunschild J, von Aspern K, Neuhaus P, Pelz J, Epstein DM, Romo-Aviles N, Piotrowski K, Etz CD (2019). Paraplegia prevention in aortic aneurysm repair by thoracoabdominal staging with 'minimally invasive staged segmental artery coil embolisation' (MIS²ACE): trial protocol for a randomised controlled multicentre trial. BMJ Open, 9(3), 025488.
     
  34. Gerner ST, Kuramatsu JB, Sembill JA, Sprugel MI, Hagen M, Knappe RU, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Mullges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stosser S, Neugebauer H, Rother J, Michels P, Schwarz M, Reimann G, Bazner H, Schwert H, Cl (2019). Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke, 50, 1392-1402.
     
  35. Riederer P, Berg D, Casadei N, Cheng F, Classen J, Dresel C, Jost W, Kruger R, Muller T, Reichmann H, Riess O, Storch A, Strobel S, van Eimeren T, Volker HU, Winkler J, Winklhofer KF, Wullner U, Zunke F, Monoranu CM (2019). ?-Synuclein in Parkinson's disease: causal or bystander? J Neural Transm (Vienna), 126(7), 815-840.
     
  36. Sprugel MI, Sembill JA, Kuramatsu JB, Gerner ST, Hagen M, Roeder SS, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Muellges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Wopking S, Ludolph AC, Stosser S, Neugebauer H, Rother J, Michels P, Schwarz M, Reimann G, Bazner H, Schwert H, (2019). Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry, 90(7), 783-791.
     
  37. Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kuhn AA, Krauss JK, Sixel-Doring F, von Eckardstein K, Deuschl G, Classen J, Winkler D, Voges J, Galazky I, Oertel W, Ceballos-Baumann AO, Lange M, Gharabaghi A, Weiss DT, Volkmann J, Heuschmann PU (2019). Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry. Parkinsonism Relat Disord, 60, 3-9.
     
  38. Esser P, Metelmann M, Hartung T, Classen J, Mehnert A, Koranyi S (2019). [Psychosocial Care For Patients With Amyotrophic Lateral Sclerosis: A Narrative Review]. Psychother Psychosom Med Psychol, 69, 372-381.
     
  39. Kuramatsu JB, Biffi A, Gerner ST, Sembill JA, Sprugel MI, Leasure A, Sansing L, Matouk C, Falcone GJ, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker J, Rizos T, Volkmann J, Mullges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stosser S, Neugebauer H, Rother J, Michels P, Schwarz M, Re (2019). Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage. JAMA, 322, 1392-1403.
     
  40. Levin J, Maass S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Sudmeyer M, Eggert K, Mollenhauer B, Lipp A, Lohle M, Classen J, Munchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Botzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Hoglinger GU (2019). Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Lancet Neurol, 18, 724-735.
     
  41. Frille A, Tegelkamp S, Lerche M, Lindner N, Rumpf JJ, Hesse S, Wirtz H (2019). Paraneoplastische neurologische Syndrome beim Lungenkarzinom Kompendium Pneumologie, 13, 42-48.
     
  42. Dorst J, Chen L, Rosenbohm A, Dreyhaupt J, Hubers A, Schuster J, Weishaupt JH, Kassubek J, Gess B, Meyer T, Weyen U, Hermann A, Winkler J, Grehl T, Hagenacker T, Lingor P, Koch JC, Sperfeld A, Petri S, Grosskreutz J, Metelmann M, Wolf J, Winkler AS, Klopstock T, Boentert M, Johannesen S, Storch A, Schrank B, Zeller D, Liu XL, Tang L, Fan DS, Ludolph AC (2019). Prognostic factors in ALS: a comparison between Germany and China. J Neurol, 266(6), 1516-1525.
     
  43. Weise D, Weise CM, Naumann M (2019). Central Effects of Botulinum Neurotoxin-Evidence from Human Studies. Toxins (Basel), 11, 1.
     
  44. van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hernandez I, van Eijk KR, Stringa N, Chen JA, Zettergren A, Andlauer TFM, Diez-Fairen M, Simon-Sanchez J, Lleo A, Zetterberg H, Nygaard M, Blauwendraat C, Savage JE, Mengel-From J, Moreno-Grau S, Wagner M, Fortea J, Keogh MJ, Blennow K, Skoog I, Friese MA, Pletnikova O, Zulaica M, Lage C, de Rojas I, Riedel-Heller S, Illan-Gala I, Wei W, Jeune B, Orellana A, Then Bergh F, Wang X, Hulsman M, Beker N, Tesi N, Morr (2019). A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol, 138, 237-250.
     
  45. Hoyer A, Then Bergh F, Klaeske K, Lehmann S, Misfeld M, Borger M, Dieterlen MT (2019). Custodiol-N? cardioplegia lowers cerebral inflammation and activation of hypoxia-inducible factor-1?. Interact Cardiovasc Thorac Surg, 28(6), 884-892.
     
  46. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgiess J, Bluher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O (2019). Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress, 22(1), 93-102.
     
  47. Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E (2019). Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial. Lancet, 394(10206), 1352-1363.
     
  48. Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, Trebst C, Warnke C, Linker R, Kerschensteiner M, Zettl U, Tumani H, Bruck W, Meuth SG, Kumpfel T, Hemmer B, Wiendl H, Gold R, Zipp F (2019). [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]. Nervenarzt, 90(12), 1245-1253.
     
  49. Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kumpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Tumani H, Gold R, Hemmer B (2019). Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis. JAMA Neurol, 76(7), 841-849.
     
  50. Johnen A, Burkner PC, Landmeyer NC, Ambrosius B, Calabrese P, Motte J, Hessler N, Antony G, Konig IR, Klotz L, Hoshi MM, Aly L, Groppa S, Luessi F, Paul F, Tackenberg B, Bergh FT, Kumpfel T, Tumani H, Stangel M, Weber F, Bayas A, Wildemann B, Heesen C, Zettl UK, Zipp F, Hemmer B, Meuth SG, Gold R, Wiendl H, Salmen A (2019). Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS). J Neurol, 266(2), 386-397.
     
  51. Berrouschot J, Köhler W, Sakowitz OW (2019). Neurointensivmedizin - kompakt In: Berrouschot J, Köhler W, Sakowitz OW, Neurointensivmedizin - kompakt (S. 1-472), Leipzig: Eigenverlag.
     


  52. 2018


  53. Meyer P, Pelz JO (2018). Blood flow reversal from the external into the internal carotid artery-New insights into the hemodynamics at the carotid bifurcation. Brain Behav, 8, e01139.
     
  54. Pelz JO, Belau E, Fricke C, Classen J, Weise D (2018). Axonal Degeneration of the Vagus Nerve in Parkinson's Disease-A High-Resolution Ultrasound Study. Front Neurol, 9, 951.
     
  55. Wawrzyniak M, Klingbeil J, Zeller D, Saur D, Classen J (2018). The neuronal network involved in self-attribution of an artificial hand: A lesion network-symptom-mapping study. Neuroimage, 166, 317-324.
     
  56. Oberstadt MCF, Esser P, Classen J, Mehnert A (2018). Alleviation of Psychological Distress and the Improvement of Quality of Life in Patients With Amyotrophic Lateral Sclerosis: Adaptation of a Short-Term Psychotherapeutic Intervention. Front Neurol, 9, 231.
     
  57. Oberstadt M, Stieler J, Simpong DL, Romuss U, Urban N, Schaefer M, Arendt T, Holzer M (2018). TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole. Sci Rep, 8, 2248.
     
  58. Hammer N, Loffler S, Cakmak YO, Ondruschka B, Planitzer U, Schultz M, Winkler D, Weise D (2018). Cervical vagus nerve morphometry and vascularity in the context of nerve stimulation - A cadaveric study. Sci Rep, 8, 7997.
     
  59. Reichel G, Kamm C, Kang JS, Mungersdorf M, Paus S, Reuter I, Stenner A, Weise D (2018). [Cervical Dystonia]. Fortschr Neurol Psychiatr, 86, 368-386.
     
  60. Kohler W, Curiel J, Vanderver A (2018). Adulthood leukodystrophies. Nat Rev Neurol, 14, 94-105.
     
  61. Michalski D, Keck AL, Grosche J, Martens H, Hartig W (2018). Immunosignals of Oligodendrocyte Markers and Myelin-Associated Proteins Are Critically Affected after Experimental Stroke in Wild-Type and Alzheimer Modeling Mice of Different Ages. Front Cell Neurosci, 12, 23.
     
  62. Mages B, Aleithe S, Altmann S, Blietz A, Nitzsche B, Barthel H, Horn AKE, Hobusch C, Hartig W, Krueger M, Michalski D (2018). Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue. Front Cell Neurosci, 12, 161.
     
  63. Baum P (2018). Neurophysiologische Diagnostik des autonomen Nervensystems Das Neurophysiologie-Labor, 40, 95-110.
     
  64. Pelz JO, Harms K, Metze M, Michalski D (2018). Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition. J Neurol, 265, 308-314.
     
  65. Rumpf JJ, Dietrich S, Stoppe M, Fricke C, Weise D, Then Bergh F, Classen J (2018). Compromised tDCS-induced facilitation of motor consolidation in patients with multiple sclerosis. J Neurol, 265, 2302-2311.
     
  66. Weise CM, Chen K, Chen Y, Kuang X, Savage CR, Reiman EM (2018). Left lateralized cerebral glucose metabolism declines in amyloid-? positive persons with mild cognitive impairment. Neuroimage Clin, 20, 286-296.
     
  67. Landmann J, Richter F, Classen J, Richter A, Penninger JM, Bechmann I (2018). Behavioral phenotyping of calcium channel (CACN) subunit ?2?3 knockout mice: Consequences of sensory cross-modal activation. Behav Brain Res, 2, 1.
     
  68. Missitzi J, Geladas N, Misitzi A, Misitzis L, Classen J, Klissouras V (2018). Heritability of proprioceptive senses. J Appl Physiol (1985), 125, 972-982.
     
  69. Mendes MI, Gutierrez Salazar M, Guerrero K, Thiffault I, Salomons GS, Gauquelin L, Tran LT, Forget D, Gauthier MS, Waisfisz Q, Smith DEC, Simons C, van der Knaap MS, Marquardt I, Lemes A, Mierzewska H (2018). Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy. Am J Hum Genet, 102, 676-684.
     
  70. Lingor P, Classen J, Herbst H, Storch A, Urban P, Wellach I, Jost WH (2018). [Treatment of end-of-dose fluctuations: the need for an individualized approach]. Fortschr Neurol Psychiatr, 86, 59-62.
     
  71. Haselmann H, Mannara F, Werner C, Planaguma J, Miguez-Cabello F, Schmidl L, Grunewald B, Petit-Pedrol M, Kirmse K, Classen J, Demir F, Klocker N, Soto D, Doose S, Dalmau J, Hallermann S, Geis C (2018). Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction. Neuron, 100, 91-105.
     
  72. Holzer M, Schade N, Opitz A, Hilbrich I, Stieler J, Vogel T, Neukel V, Oberstadt M, Totzke F, Schachtele C, Sippl W, Hilgeroth A (2018). Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay. Molecules, 23, 1.
     
  73. Hewett K, Sanders DB, Grove RA, Broderick CL, Rudo TJ, Bassiri A, Zvartau-Hind M, Bril V (2018). Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis. Neurology, 90, 1425-1434.
     
  74. von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Tackenberg B, Stoppe M, Then Bergh F, Tumani H, Kumpfel T, Stangel M, (2018). Treatment choices and neuropsychological symptoms of a large cohort of early MS. Neurol Neuroimmunol Neuroinflamm, 5, 446.
     
  75. Mueller SH, Farber A, Pruss H, Melzer N, Golombeck KS, Kumpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Suhs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, (2018). Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol, 83, 863-869.
     
  76. Branzan D, Etz CD, Moche M, Von Aspern K, Staab H, Fuchs J, Then Bergh F, Scheinert D, Schmidt A (2018). Ischaemic preconditioning of the spinal cord to prevent spinal cord ischaemia during endovascular repair of thoracoabdominal aortic aneurysm: first clinical experience. EuroIntervention, 14, 828-835.
     
  77. Heine J, Pruss H, Kopp UA, Wegner F, Then Bergh F, Munte T, Wandinger KP, Paul F, Bartsch T, Finke C (2018). Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis. J Neurol Neurosurg Psychiatry, 89, 1191-1199.
     
  78. Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, Ruprecht K, Havla J, Kumpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm (2018). Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions. Neurol Neuroimmunol Neuroinflamm, 5, 504.
     
  79. Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgiess J, Bluher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O (2018). Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress, 29, 1-10.
     
  80. Mendes MI, Gutierrez Salazar M, Guerrero K, Thiffault I, Salomons GS, Gauquelin L, Tran LT, Forget D, Gauthier MS, Waisfisz Q, Smith DEC, Simons C, van der Knaap MS, Marquardt I, Lemes A, Mierzewska H (2018). Bi-allelic Mutations in EPRS, Encoding the Glutamyl-Prolyl-Aminoacyl-tRNA Synthetase, Cause a Hypomyelinating Leukodystrophy. Am J Hum Genet, 102, 676-684.
     
  81. Hoffmann F, Kraft A, Heigl F, Mauch E, Koehler J, Harms L, Kumpfel T, Kohler W, Ehrlich S, Bayas A, Weinmann-Menke J, Beuker C, Henn KH, Ayzenberg I, Ellrichmann G, Hellwig K, Klingel R, Fassbender CM (2018). Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica. Ther Adv Neurol Disord, 11, 1-12.
     
  82. Weinhofer I, Zierfuss B, Hametner S, Wagner M, Popitsch N, Machacek C, Bartolini B, Zlabinger G, Ohradanova-Repic A, Stockinger H, Kohler W, Hoftberger R, Regelsberger G, Forss-Petter S, Lassmann H, B (2018). Impaired plasticity of macrophages in X-linked adrenoleukodystrophy. Brain, 30, 1.
     
  83. Waldhuter N, Kohler W, Hemmati PG, Jehn C, Peceny R, Vuong GL, Arnold R, Kuhl JS (2018). Allogeneic haematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophy. J Inherit Metab Dis, 21, 1.
     
  84. Beeskow AB, Oberstadt M, Saur D, Hoffmann KT, Lobsien D (2018). Delayed Post-hypoxic Leukoencephalopathy (DPHL)-An Uncommon Variant of Hypoxic Brain Damage in Adults. Front Neurol, 9, 708.
     
  85. Steinacker P, Verde F, Fang L, Feneberg E, Oeckl P, Roeber S, Anderl-Straub S, Danek A, Diehl-Schmid J, Fassbender K, Fliessbach K, Foerstl H, Giese A, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer G (2018). Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. J Neurol Neurosurg Psychiatry, 89, 239-247.
     
  86. Florek L, Tiepolt S, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Luthardt J, Sattler B, Patt M, Hoffmann KT, Villringer A, Classen J, Gertz HJ, Sabri O, Barthel H (2018). Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease. J Alzheimers Dis, 66, 1105-1116.
     
  87. Friedrich B, Maegerlein C, Lobsien D, Monch S, Berndt M, Hedderich D, Wunderlich S, Michalski D, Lehm M, Boeckh-Behrens T, Zimmer C, Kreiser K (2018). Endovascular Stroke Treatment on Single-Plane vs. Bi-Plane Angiography Suites : Technical Considerations and Evaluation of Treatment Success. Clin Neuroradiol, 2, 1.
     
  88. Gerner ST, Kuramatsu JB, Sembill JA, Sprugel MI, Endres M, Haeusler KG, Vajkoczy P, Ringleb PA, Purrucker J, Rizos T, Erbguth F, Schellinger PD, Fink GR, Stetefeld H, Schneider H, Neugebauer H, Rother (2018). Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Ann Neurol, 83, 186-196.
     
  89. Kuramatsu JB, Sembill JA, Gerner ST, Sprugel MI, Hagen M, Roeder SS, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker J, Rizos T, Volkmann J, Mullges (2018). Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J, 39, 1709-1723.
     
  90. Bankstahl M, Breuer H, Leiter I, Markel M, Bascunana P, Michalski D, Bengel FM, Loscher W, Meier M, Bankstahl JP, Hartig W (2018). Blood-Brain Barrier Leakage during Early Epileptogenesis Is Associated with Rapid Remodeling of the Neurovascular Unit. eNeuro, 5, 1.
     
  91. Reuss CJ, Bernhard M, Beynon C, Hecker A, Jungk C, Nusshag C, Weigand MA, Michalski D, Brenner T (2018). [Intensive care studies from 2017/2018]. Anaesthesist, 67, 679-708.
     
  92. Kosacka J, Nowicki M, Paeschke S, Baum P, Bluher M, Kloting N (2018). Up-regulated autophagy: as a protective factor in adipose tissue of WOKW rats with metabolic syndrome. Diabetol Metab Syndr, 10, 13.
     
  93. Hellmich D, Wartenberg KE, Zierz S, Mueller TJ (2018). Foodborne botulism due to ingestion of home-canned green beans: two case reports. J Med Case Rep, 12, 1.
     
  94. Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph AC, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Mu (2018). Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach. Amyotroph Lateral Scler Frontotemporal Degener, 19, 342-350.
     
  95. van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ (2018). Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol, 17, 35-46.
     
  96. Haimon Z, Volaski A, Orthgiess J, Boura-Halfon S, Varol D, Shemer A, Yona S, Zuckerman B, David E, Chappell-Maor L, Bechmann I, Gericke M, Ulitsky I, Jung S (2018). Re-evaluating microglia expression profiles using RiboTag and cell isolation strategies. Nat Immunol, 19, 636-644.
     
  97. Loewenbruck KF, Dittrich M, Bohm J, Klingelhofer J, Baum P, Schafer J, Reichmann H, Hermann A, Storch A (2018). Practically applicable nerve ultrasound models for the diagnosis of axonal and demyelinating hereditary motor and sensory neuropathies (HMSN). J Neurol, 265(1), 165-177.
     
  98. Landmann J, Richter F, Oros-Peusquens AM, Shah NJ, Classen J, Neely GG, Richter A, Penninger JM, Bechmann I (2018). Neuroanatomy of pain-deficiency and cross-modal activation in calcium channel subunit (CACN) ?2?3 knockout mice. Brain Struct Funct, 223(1), 111-130.
     
  99. Meyer HJ, Rumpf JJ, Hoffmann KT, Lobsien D (2018). [Perfusion and spectroscopy of progressive multifocal leucencephalopathy]. Rofo, 25, 1.
     
  100. Tadic V, Adam A, Goldhammer N, Lautenschlaeger J, Oberstadt M, Malci A, Le TT, Sengupta S, Stubendorff B, Keiner S, Witte OW, Grosskreutz J (2018). Investigation of mitochondrial calcium uniporter role in embryonic and adult motor neurons from G93AhSOD1 mice. Neurobiol Aging, 75, 209-222.
     
  101. Kuhl JS, Kupper J, Baque H, Ebell W, Gartner J, Korenke C, Spors B, Steffen IG, Strauss G, Voigt S, Weschke B, Weddige A, Kohler W, Steinfeld R (2018). Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy. JAMA Netw Open, 1, 180769.
     
  102. Hamilton EMC, Tekturk P, Cialdella F, van Rappard DF, Wolf NI, Yalcinkaya C, Cetincelik U, Rajaee A, Kariminejad A, Paprocka J, Yapici Z, Bosnjak VM, van der Knaap MS (2018). Megalencephalic leukoencephalopathy with subcortical cysts: Characterization of disease variants. Neurology, 90, 1395-1403.
     
  103. International MS Genetics Consortium, Cotsapas C (2018). Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell, 175, 1679-1687.
     
  104. Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallstrom E, Dahlke F (2018). Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet, 391, 1263-1273.
     
  105. Köhler W (2018). Leukodystrophien In: Zettl U, Sieb J, Diagnostik und Therapie neurologischer Erkrankungen (S. 419-434), München: Elsevier Verlag.
     
  106. Wartenberg KE, Mayer SA (2018). Trauma In: Brust JCM, Current Diagnosis & Treatment in Neurology (S. 175-192), New York, NY: Mc Graw Hill.
     
  107. Berrouschot J, Köhler W, Sakowitz OW (2018). Neurointensivmedizin - kompakt In: Berroutschot J, Köhler W, Sakowitz OW, Neurointensivmedizin - kompakt (S. 1-160), Leipzig: Eigenverlag.
     


  108. 2017


  109. Fassbender C, Klingel R, Kohler W (2017). Immunoadsorption for autoimmune encephalitis. Atheroscler Suppl, 30, 257-263.
     
  110. Kohler W, Fischer M, Bublak P, Faiss JH, Hoffmann F, Kunkel A, Sailer M, Schwab M, Stadler E, Zettl UK, Penner IK (2017). Information processing deficits as a driving force for memory impairment in MS: A cross--sectional study of memory functions and MRI in early and late stage MS. Mult Scler Relat Disord, 18, 119-127.
     
  111. Krueger M, Hartig W, Frydrychowicz C, Mueller WC, Reichenbach A, Bechmann I, Michalski D (2017). Stroke-induced blood-brain barrier breakdown along the vascular tree - No preferential affection of arteries in different animal models and in humans. J Cereb Blood Flow Metab, 37(7), 2539-2554.
     
  112. Pelz JO, Michalski D, Saur D (2017). Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema. eNeurologicalSci, 8, 36-37.
     
  113. Pelz JO, Busch M, Weinreich A, Saur D, Weise D (2017). Evaluation Of freehand high-resolution 3-dimensional ultrasound of the median nerve. Muscle Nerve, 55(2), 206-212.
     
  114. Pelz JO, Weinreich A, Karlas T, Saur D (2017). Evaluation of Freehand B-Mode and Power-Mode 3D Ultrasound for Visualisation and Grading of Internal Carotid Artery Stenosis. PLoS One, 12(1), e0167500.
     
  115. Hartig W, Mages B, Aleithe S, Nitzsche B, Altmann S, Barthel H, Krueger M, Michalski D (2017). Damaged Neocortical Perineuronal Nets Due to Experimental Focal Cerebral Ischemia in Mice, Rats and Sheep. Front Integr Neurosci, 11, 15.
     
  116. Michalski D, Hofmann S, Pitsch R, Grosche J, Hartig W (2017). Neurovascular Specifications in the Alzheimer-Like Brain of Mice Affected by Focal Cerebral Ischemia: Implications for Future Therapies. J Alzheimers Dis, 59(2), 655-674.
     
  117. Michalski D, Pitsch R, Pillai DR, Mages B, Aleithe S, Grosche J, Martens H, Schlachetzki F, Hartig W (2017). Delayed histochemical alterations within the neurovascular unit due to transient focal cerebral ischemia and experimental treatment with neurotrophic factors. PLoS One, 12(4), e0174996.
     
  118. Pelz JO, Michalski D (2017). Auf den Schlaganfall fokussierte neurologische Untersuchung und Implikationen für den Rettungsdienst - Schritt für Schritt. Notfallmedizin Update 2017, 12, 126-138.
     
  119. Fricke L, Petroff D, Desch S, Lurz P, Reinhardt S, Sonnabend M, Classen J, Baum P (2017). Does dysfunction of the autonomic nervous system affect success of renal denervation in reducing blood pressure? SAGE Open Med, 5, 2050312117702031.
     
  120. Wirsching I, Buttmann M, Odorfer T, Volkmann J, Classen J, Zeller D (2017). Altered motor plasticity in an acute relapse of multiple sclerosis. Eur J Neurosci, 00, 00.
     
  121. Rumpf JJ, Albers J, Fricke C, Mueller W, Classen J (2017). Structural abnormality of substantia nigra induced by methamphetamine abuse. Mov Disord, 32(12), 1784-1788.
     
  122. Pelz JO, Belau E, Henn P, Hammer N, Classen J, Weise D (2017). Sonographic evaluation of the vagus nerves: Protocol, reference values, and side-to-side differences. Muscle Nerve, 00, 00.
     
  123. Suppa A, Quartarone A, Siebner H, Chen R, Di Lazzaro V, Del Giudice P, Paulus W, Rothwell JC, Ziemann U, Classen J (2017). The associative brain at work: Evidence from paired associative stimulation studies in humans. Clin Neurophysiol, 128, 2140-2164.
     
  124. Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, Wullner U, Storch A (2017). Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues. J Neural Transm (Vienna), 124(8), 1029-1036.
     
  125. Classen J, Saur D, Fink GR (2017). [Network disorders in neurology]. Nervenarzt, 88(8), 837-838.
     
  126. Fricke C, Gentner R, Rumpf JJ, Weise D, Saur D, Classen J (2017). Differential spatial representation of precision and power grasps in the human motor system. Neuroimage, 158, 58-69.
     
  127. Hartwigsen G, Bzdok D, Klein M, Wawrzyniak M, Stockert A, Wrede K, Classen J, Saur D (2017). Rapid short-term reorganization in the language network. Elife, 6, e25964.
     
  128. Wawrzyniak M, Hoffstaedter F, Klingbeil J, Stockert A, Wrede K, Hartwigsen G, Eickhoff SB, Classen J, Saur D (2017). Fronto-temporal interactions are functionally relevant for semantic control in language processing. PLoS One, 12(5), e0177753.
     
  129. Oberstadt M, Classen J, Arendt T, Holzer M (2017). TDP-43 and Cytoskeletal Proteins in ALS. Mol Neurobiol, 00, 00.
     
  130. Rumpf JJ, Wegscheider M, Hinselmann K, Fricke C, King BR, Weise D, Klann J, Binkofski F, Buccino G, Karni A, Doyon J, Classen J (2017). Enhancement of motor consolidation by post-training transcranial direct current stimulation in older people. Neurobiol Aging, 49, 1-8.
     
  131. Weise D, Mann J, Rumpf JJ, Hallermann S, Classen J (2017). Differential Regulation of Human Paired Associative Stimulation-Induced and Theta-Burst Stimulation-Induced Plasticity by L-type and T-type Ca2+ Channels. Cereb Cortex, 27(8), 4010-4021.
     
  132. Weise D (2017). Wann Sonographie peripherer Nerven? Indication of peripheral nerve sonography. Neurophysiol Lab, 39(1), 34-44.
     
  133. Weise CM, Piaggi P, Reinhardt M, Chen K, Savage CR, Krakoff J, Pleger B (2017). The obese brain as a heritable phenotype: a combined morphometry and twin study. Int J Obes (Lond), 41(3), 458-466.
     
  134. Hartwigsen G, Saur D (2017). Neuroimaging of stroke recovery from aphasia - Insights into plasticity of the human language network. Neuroimage, 00, 00.
     
  135. Klingbeil J, Wawrzyniak M, Stockert A, Saur D (2017). Resting-state functional connectivity: An emerging method for the study of language networks in post-stroke aphasia. Brain Cogn, 00, -.
     
  136. Stockert A, Saur D (2017). [Aphasia: a neuronal network disorder]. Nervenarzt, 88(8), 866-873.
     
  137. Weise G, Posel C, Moller K, Kranz A, Didwischus N, Boltze J, Wagner DC (2017). High-dosage granulocyte colony stimulating factor treatment alters monocyte trafficking to the brain after experimental stroke. Brain Behav Immun, 60, 15-26.
     
  138. Stoppe M, Busch M, Krizek L, Then Bergh F (2017). Outcome of MS relapses in the era of disease-modifying therapy. BMC Neurol, 17(1), 151.
     
  139. Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Bluher M, Kratzsch J, Then Bergh F (2017). Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity. Psychoneuroendocrinology, 78, 39-47.
     
  140. Schwartzbach CJ, Grove RA, Brown R, Tompson D, Then Bergh F, Arnold DL (2017). Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study. J Neurol, 264(2), 304-315.
     
  141. Borisow N, Kleiter I, Gahlen A, Fischer K, Wernecke KD, Pache F, Ruprecht K, Havla J, Krumbholz M, Kumpfel T, Aktas O, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer B, Angstwurm K, Weisser (2017). Influence of female sex and fertile age on neuromyelitis optica spectrum disorders. Mult Scler, 23(8), 1092-1103.
     
  142. Planitzer U, Hammer N, Bechmann I, Glatzner J, Loffler S, Mobius R, Tillmann BN, Weise D, Winkler D (2017). Positional Relations of the Cervical Vagus Nerve Revisited. Neuromodulation, 20(4), 361-368.
     
  143. Alkemade A, de Hollander G, Keuken MC, Schafer A, Ott DVM, Schwarz J, Weise D, Kotz SA, Forstmann BU (2017). Comparison of T2*-weighted and QSM contrasts in Parkinsons disease to visualize the STN with MRI. PLoS One, 12(4), e0176130.
     
  144. Voigt P, Schob S, Jantschke R, Nestler U, Krause M, Weise D, Lobsien D, Hoffmann KT, Quaschling U (2017). Stent-Assisted Coiling of Ruptured and Incidental Aneurysms of the Intracranial Circulation Using Moderately Flow-Redirecting, Braided Leo Stents-Initial Experience in 39 Patients. Front Neurol, 8, 602.
     
  145. Finke C, Pruss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Munte T, Deuschl G, Ruprecht K, Stocker W, Wandinger KP, Paul F, Bartsch T (2017). Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol, 74(1), 50-59.
     
  146. Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Sacca F, Bergh FT, Bartezaghi M, Turrini R, Filippi M (2017). Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study). J Neurol, 264(12), 2436-2449.
     
  147. Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, de Koning TJ, Degtyareva A, Dionisi-Vici C, Doss S, Duning T, Giunti P, Iodice R, Johnston T, Kelly D, Klunemann HH, Lorenzl S, Pado (2017). The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Curr Med Res Opin, 33(5), 877-890.
     
  148. Stellmann JP, Krumbholz M, Friede T, Gahlen A, Borisow N, Fischer K, Hellwig K, Pache F, Ruprecht K, Havla J, Kumpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele A, Hemmer (2017). Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response. J Neurol Neurosurg Psychiatry, 88(8), 639-647.
     
  149. Fam MD, Zeineddine HA, Eliyas JK, Stadnik A, Jesselson M, McBee N, Lane K, Cao Y, Wu M, Zhang L, Thompson RE, John S, Ziai W, Hanley DF, Awad IA (2017). CSF inflammatory response after intraventricular hemorrhage. Neurology, 89(15), 1553-1560.
     
  150. Reuss CJ, Bernhard M, Beynon C, Hecker A, Jungk C, Michalski D, Nusshag C, Weigand MA, Brenner T (2017). [Intensive care studies from 2016/2017]. Anaesthesist, 66(9), 690-713.
     
  151. Gawlitza M, Bohme J, Maros M, Lobsien D, Michalski D, Groden C, Hoffmann KT, Forster A (2017). FLAIR vascular hyperintensities and 4D MR angiograms for the estimation of collateral blood flow in anterior cerebral artery ischemia. PLoS One, 12(2), e0172570.
     
  152. Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY (2017). The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2. J Am Coll Cardiol, 69(7), 777-785.
     
  153. Demuth HU, Dijkhuizen RM, Farr TD, Gelderblom M, Horsburgh K, Iadecola C, Mcleod DD, Michalski D, Murphy TH, Orbe J, Otte WM, Petzold GC, Plesnila N, Reiser G, Reymann KG, Rueger MA, Saur D, Savitz SI (2017). Recent progress in translational research on neurovascular and neurodegenerative disorders. Restor Neurol Neurosci, 35(1), 87-103.
     
  154. Huang YZ, Lu MK, Antal A, Classen J, Nitsche M, Ziemann U, Ridding M, Hamada M, Ugawa Y, Jaberzadeh S, Suppa A, Paulus W, Rothwell J (2017). Plasticity induced by non-invasive transcranial brain stimulation: A position paper. Clin Neurophysiol, 128(11), 2318-2329.
     
  155. Buch ER, Santarnecchi E, Antal A, Born J, Celnik PA, Classen J, Gerloff C, Hallett M, Hummel FC, Nitsche MA, Pascual-Leone A, Paulus WJ, Reis J, Robertson EM, Rothwell JC, Sandrini M, Schambra HM, Was (2017). Effects of tDCS on motor learning and memory formation: A consensus and critical position paper. Clin Neurophysiol, 128(4), 589-603.
     
  156. King BR, Saucier P, Albouy G, Fogel SM, Rumpf JJ, Klann J, Buccino G, Binkofski F, Classen J, Karni A, Doyon J (2017). Cerebral Activation During Initial Motor Learning Forecasts Subsequent Sleep-Facilitated Memory Consolidation in Older Adults. Cereb Cortex, 27(2), 1588-1601.
     
  157. Heinitz S, Reinhardt M, Piaggi P, Weise CM, Diaz E, Stinson EJ, Venti C, Votruba SB, Wassermann EM, Alonso-Alonso M, Krakoff J, Gluck ME (2017). Neuromodulation directed at the prefrontal cortex of subjects with obesity reduces snack food intake and hunger in a randomized trial. Am J Clin Nutr, 106(6), 1347-1357.
     
  158. Martin M, Dressing A, Bormann T, Schmidt CSM, Kummerer D, Beume L, Saur D, Mader I, Rijntjes M, Kaller CP, Weiller C (2017). Componential Network for the Recognition of Tool-Associated Actions: Evidence from Voxel-based Lesion-Symptom Mapping in Acute Stroke Patients. Cereb Cortex, 27(8), 4139-4152.
     
  159. Schlachetzki F, Nadelmann M, Poppert H, Saur D, Harloff A, Liman J, Reinhardt M, Stolz E, Kaps M (2017). Neurosonology makes the Difference in Acute Stroke Care. Aktuelle Neurologie, 44(7), 501-508.
     
  160. Boltze J, Nitzsche F, Jolkkonen J, Weise G, Posel C, Nitzsche B, Wagner DC (2017). Concise Review: Increasing the Validity of Cerebrovascular Disease Models and Experimental Methods for Translational Stem Cell Research. Stem Cells, 35(5), 1141-1153.
     
  161. Drabe M, Rullmann M, Luthardt J, Boettcher Y, Regenthal R, Ploetz T, Becker GA, Patt M, Schinke C, Bergh FT, Zientek F, Hilbert A, Bresch A, Fenske W, Hankir MK, Sabri O, Hesse S (2017). Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Transl Psychiatry, 7(7), e1167.
     
  162. Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew (2017). Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med, 376(3), 209-220.
     
  163. Matzen P, Deschauer M, Kornhuber M, Nestler U (2017). Grundzüge der Diagnostik. In: Matzen P, Deschauer M, Kornhuber M, Nestler U, Neuroorthopädie. (S. 71-101), Berlin: De Gruyter.
     


  164. 2016


  165. Hartwigsen G, Weigel A, Schuschan P, Siebner HR, Weise D, Classen J, Saur D (2016). Dissociating Parieto-Frontal Networks for Phonological and Semantic Word Decisions: A Condition-and-Perturb TMS Study. Cereb Cortex, 26(6), 2590-2601.
     
  166. Hobohm C, Hagendorff A, Schulz S, Fritzsch D, Budig S, Stobe S, Michalski D (2016). Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis. Cerebrovasc Dis, 41(1-2), 60-67.
     
  167. Oberstadt M, Mitter D, Classen J, Baum P (2016). Late onset dHMN II caused by c.404C>G mutation in HSPB1 gene. J Peripher Nerv Syst, 21(2), 111-113.
     
  168. Baum P, Kosacka J, Estrela-Lopis I, Woidt K, Serke H, Paeschke S, Stockinger M, Kloting N, Bluher M, Dorn M, Classen J, Thiery J, Bechmann I, Toyka KV, Nowicki M (2016). The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN). Metabolism, 65(4), 391-405.
     
  169. Saur D (2016). Commentary on Bajada et al., (2015). Cortex, 75, 247-248.
     
  170. Zeller D, Friston KJ, Classen J (2016). Dynamic causal modeling of touch-evoked potentials in the rubber hand illusion. Neuroimage, 138, 266-273.
     
  171. Rumpf JJ, Wegscheider M, Hinselmann K, Fricke C, King BR, Weise D, Klann J, Binkofski F, Buccino G, Karni A, Doyon J, Classen J (2016). Enhancement of motor consolidation by post-training transcranial direct current stimulation in older people. Neurobiol Aging, 49, 1-8.
     
  172. Reinhardt M, Parigi AD, Chen K, Reiman EM, Thiyyagura P, Krakoff J, Hohenadel MG, Le DS, Weise CM (2016). Deactivation of the left dorsolateral prefrontal cortex in Prader-Willi syndrome after meal consumption. Int J Obes (Lond), 40(9), 1360-1368.
     
  173. Posel C, Moller K, Boltze J, Wagner DC, Weise G (2016). Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain. J Vis Exp, 108, 53658.
     
  174. Weise D, Hammer N, Rumpf JJ, Fritzsch D, Meixensberger J, Schwarz J, Winkler D (2016). Unilateral multi-target deep brain stimulation in hemichoreodystonia following ischemic thalamic stroke. Basal Ganglia, 6(3), 153-156.
     
  175. Weise D (2016). Vestibulär evozierte myogene Potentiale in der Neurologie. Das Neurophysiologie Labor, 38(2), 85-92.
     
  176. Hartig W, Appel S, Suttkus A, Grosche J, Michalski D (2016). Abolished perineuronal nets and altered parvalbumin-immunoreactivity in the nucleus reticularis thalami of wildtype and 3xTg mice after experimental stroke. Neuroscience, 337, 66-87.
     
  177. Hartig W, Krueger M, Hofmann S, Preissler H, Markel M, Frydrychowicz C, Mueller WC, Bechmann I, Michalski D (2016). Up-regulation of neurofilament light chains is associated with diminished immunoreactivities for MAP2 and tau after ischemic stroke in rodents and in a human case. J Chem Neuroanat, 78, 140-148.
     
  178. Michalski D, Preissler H, Hofmann S, Kacza J, Hartig W (2016). Decline of microtubule-associated protein tau after experimental stroke in differently aged wild-type and 3xTg mice with Alzheimer-like alterations. Neuroscience, 330, 1-11.
     
  179. Stockert A, Kummerer D, Saur D (2016). Insights into early language recovery: from basic principles to practical applications. Aphasiology, 30(5), 517-541.
     
  180. Hamzei F, Vry MS, Saur D, Glauche V, Hoeren M, Mader I, Weiller C, Rijntjes M (2016). The Dual-Loop Model and the Human Mirror Neuron System: an Exploratory Combined fMRI and DTI Study of the Inferior Frontal Gyrus. Cereb Cortex, 26(5), 2215-2224.
     
  181. Hiegel T, Zajonz D, Baum P, Lingscheidt T, Brandmaier P, Winkler D, Prietzel T (2016). [Unusual finding in a 50-year-old patient with lumboischialgia and unilateral foot drop]. Chirurg, 87(2), 157-161.
     
  182. Gawlitza M, Friedrich B, Hobohm C, Schaudinn A, Schob S, Quaschling U, Hoffmann KT, Lobsien D (2016). Distance to Thrombus in Acute Middle Cerebral Artery Occlusion Predicts Target Mismatch and Ischemic Penumbra. J Stroke Cerebrovasc Dis, 25(2), 298-305.
     
  183. Lobsien D, Gawlitza M, Schaudinn A, Schob S, Hobohm C, Fritzsch D, Quaschling U, Hoffmann KT, Friedrich B (2016). Mechanical thrombectomy versus systemic thrombolysis in MCA stroke: a distance to thrombus-based outcome analysis. J Neurointerv Surg, 8(9), 878-882.
     
  184. Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, Pache F, Ruprecht K, Havla J, Krumbholz M, Kumpfel T, Aktas O, Hartung HP, Ringelstein M, Geis C, Kleinschnitz C, Berthele (2016). Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol, 79(2), 206-216.
     
  185. Trawinski H, Bruning JH, Baum P, Ziemer M, Schubert S, Lubbert C (2016). [Borderline leprosy as a rare differential diagnosis]. Dtsch Med Wochenschr, 141(11), 806-810.
     
  186. Loewenbruck KF, Dittrich M, Bohm J, Klingelhofer J, Baum P, Schafer J, Koch R, Storch A (2016). Diagnostic accuracy of nerve ultrasound in hereditary and sporadic non-entrapment neuropathies. J Neurol, 263(11), 2196-2206.
     
  187. Schob S, Lobsien D, Friedrich B, Bernhard MK, Gebauer C, Dieckow J, Gawlitza M, Pirlich M, Saur D, Brauer L, Bechmann I, Hoffmann KT, Mahr CV, Nestler U, Preuss M (2016). The Cerebral Surfactant System and Its Alteration in Hydrocephalic Conditions. PLoS One, 11(9), e0160680.
     
  188. Schutz L, Lobsien D, Fritzsch D, Tiepolt S, Werner P, Schroeter ML, Berrouschot J, Saur D, Hesse S, Jochimsen T, Rullmann M, Sattler B, Patt M, Gertz HJ, Villringer A, Classen J, Hoffmann KT, Sabri O, (2016). Feasibility and acceptance of simultaneous amyloid PET/MRI. Eur J Nucl Med Mol Imaging, 43(12), 2236-2243.
     
  189. Werner P, Saur D, Mildner T, Moller H, Classen J, Sabri O, Hoffmann KT, Barthel H (2016). Combined PET/MRI: Multimodality insights into acute stroke hemodynamics. Neurology, 86(20), 1926-1927.
     
  190. Ossig C, Antonini A, Buhmann C, Classen J, Csoti I, Falkenburger B, Schwarz M, Winkler J, Storch A (2016). Wearable sensor-based objective assessment of motor symptoms in Parkinsons disease. J Neural Transm (Vienna), 123(1), 57-64.
     
  191. Levin J, Maass S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Berg D, Classen J, Ebersbach G, Eggert K, Kassubek J, Lipp A, Lohle M, Mol (2016). Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. J Neural Transm (Vienna), 123(11), 1357-1358.
     
  192. Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kumpfel T, Limmroth V, Linker RA, Loleit V, Luessi F, M (2016). Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. Sci Adv, 2(6), e1501678.
     
  193. Ayzenberg I, Schollhammer J, Hoepner R, Hellwig K, Ringelstein M, Aktas O, Kumpfel T, Krumbholz M, Trebst C, Paul F, Pache F, Obermann M, Zeltner L, Schwab M, Berthele A, Jarius S, Kleiter I (2016). Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study. J Neurol, 263(3), 575-582.
     
  194. Buchner H, Klinker F, Kunesch E, Scheglmann K, Weise D, Milnik V (2016). Evozierte Potentiale (Somatosensibel-, frühe akustische evozierte Potentiale; SEP, FAEP) zum Irreversibilitätsnachweis der klinischen Ausfallssymptome des Gehirns. Klin Neurophysiologie, 47(1), 33-39.
     
  195. Tiepolt S, Hesse S, Patt M, Luthardt J, Schroeter ML, Hoffmann KT, Weise D, Gertz HJ, Sabri O, Barthel H (2016). Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimers disease. Eur J Nucl Med Mol Imaging, 43(9), 1700-1709.
     
  196. Reuss CJ, Bernhard M, Beynon C, Hofer S, Jungk C, Michalski D, Weigand MA, Brenner T (2016). [Intensive care studies from 2015/2016]. Anaesthesist, 65(7), 532-552.
     
  197. Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW (2016). Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med, 375(11), 1033-1043.
     
  198. Huss AM, Halbgebauer S, Ockl P, Trebst C, Spreer A, Borisow N, Harrer A, Brecht I, Balint B, Stich O, Schlegel S, Retzlaff N, Winkelmann A, Roesler R, Lauda F, Yildiz O, Voss E, Muche R, Rauer S, Berg (2016). Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome. J Neurol, 263(12), 2499-2504.
     


  199. 2015


  200. Baum P, Classen J (2015). Long-term recovery in critical illness myopathy is complete, contrary to polyneuropathy. Muscle Nerve, 51(4), 624-625.
     
  201. Bluher S, Petroff D, Keller A, Wagner A, Classen J, Baum P (2015). Effect of a 1-Year Obesity Intervention (KLAKS Program) on Preexisting Autonomic Nervous Dysfunction in Childhood Obesity. J Child Neurol, 30(9), 1174-1181.
     
  202. Hartwigsen G, Golombek T, Obleser J (2015). Repetitive transcranial magnetic stimulation over left angular gyrus modulates the predictability gain in degraded speech comprehension. Cortex, 68, 100-110.
     
  203. Zeller D, Litvak V, Friston KJ, Classen J (2015). Sensory Processing and the Rubber Hand Illusion-An Evoked Potentials Study. J Cogn Neurosci, 27(3), 573-582.
     
  204. Pelz JO, Weinreich A, Fritzsch D, Saur D (2015). Quantification of Internal Carotid Artery Stenosis with 3D Ultrasound Angiography. Ultraschall Med, 36(5), 487-493.
     
  205. Keller L, Hobohm C, Zeynalova S, Classen J, Baum P (2015). Does treatment with t-PA increase the risk of developing epilepsy after stroke? J Neurol, 262(10), 2364-2372.
     
  206. Weise D, Adamidis M, Pizzolato F, Rumpf JJ, Fricke C, Classen J (2015). Assessment of brainstem function with auricular branch of vagus nerve stimulation in Parkinsons disease. PLoS One, 10(4), e0120786.
     
  207. Pelz JO, Fricke C, Saur D, Classen J (2015). Failure to confirm benefit of acetyl-DL-leucine in degenerative cerebellar ataxia: a case series. J Neurol, 262(5), 1373-1375.
     
  208. Rumpf JJ, Schirmer M, Fricke C, Weise D, Wagner JA, Simon J, Classen J (2015). Light pigmentation phenotype is correlated with increased substantia nigra echogenicity. Mov Disord, 30(13), 1848-1852.
     
  209. Weise D, Tiepolt S, Awissus C, Hoffmann KT, Lobsien D, Kaiser T, Barthel H, Sabri O, Gertz HJ (2015). Critical Comparison of Different Biomarkers for Alzheimers Disease in a Clinical Setting. J Alzheimers Dis, 48(2), 425-432.
     
  210. Michalski D, Hartig W, Krueger M, Hobohm C, Kas JA, Fuhs T (2015). A novel approach for mechanical tissue characterization indicates decreased elastic strength in brain areas affected by experimental thromboembolic stroke. Neuroreport, 26(10), 583-587.
     
  211. Krueger M, Bechmann I, Immig K, Reichenbach A, Hartig W, Michalski D (2015). Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia. J Cereb Blood Flow Metab, 35(2), 292-303.
     
  212. Hobohm C, Michalski D (2015). Neurologische Basisdiagnostik im Rettungsdienst Notfallmedizin up2date, 10(3), 257-268.
     
  213. Weise CM, Mouton PR, Eschbacher J, Coons SW, Krakoff J (2015). A post-mortem stereological study of striatal cell number in human obesity. Obesity (Silver Spring), 23(1), 100-104.
     
  214. Weise CM, Thiyyagura P, Reiman EM, Chen K, Krakoff J (2015). A potential role for the midbrain in integrating fat-free mass determined energy needs: An H2 (15) O PET study. Hum Brain Mapp, 36(6), 2406-2415.
     
  215. Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, Kniess T, Schmitz B, Bernedo V, Ruckes C, Ehrlich A, Kramer G (2015). A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia, 56(3), 450-459.
     
  216. Schwartze M, Stockert A, Kotz SA (2015). Striatal contributions to sensory timing: Voxel-based lesion mapping of electrophysiological markers. Cortex, 71, 332-340.
     
  217. Kuramatsu JB, Gerner ST, Schellinger PD, Glahn J, Endres M, Sobesky J, Flechsenhar J, Neugebauer H, Juttler E, Grau A, Palm F, Rother J, Michels P, Hamann GF, Huwel J, Hagemann G, Barber B, Terborg C, (2015). Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA, 313(8), 824-836.
     
  218. Karabanov A, Ziemann U, Hamada M, George MS, Quartarone A, Classen J, Massimini M, Rothwell J, Siebner HR (2015). Consensus Paper: Probing Homeostatic Plasticity of Human Cortex With Non-invasive Transcranial Brain Stimulation. Brain Stimul, 8(3), 442-454.
     
  219. Werner P, Saur D, Zeisig V, Ettrich B, Patt M, Sattler B, Jochimsen T, Lobsien D, Meyer PM, Bergh FT, Dreyer A, Boltze J, Classen J, Fritzsch D, Hoffmann KT, Sabri O, Barthel H (2015). Simultaneous PET/MRI in stroke: a case series. J Cereb Blood Flow Metab, 35(9), 1421-1425.
     
  220. Matzke C, Lindner D, Schwarz J, Classen J, Hammer N, Weise D, Rumpf JJ, Fritzsch D, Meixensberger J, Winkler D (2015). A comparison of two surgical approaches in functional neurosurgery: individualized versus conventional stereotactic frames. Comput Aided Surg, 20(1), 34-40.
     
  221. Jensen MM, Arvaniti M, Mikkelsen JD, Michalski D, Pinborg LH, Hartig W, Thomsen MS (2015). Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimers disease. Neurobiol Aging, 36(4), 1629-1638.
     
  222. Gawlitza M, Friedrich B, Quaschling U, Schob S, Schaudinn A, Hobohm C, Hoffmann KT, Lobsien D (2015). Distance to thrombus on MR angiography predicts outcome of middle cerebral artery occlusion treated with IV thrombolysis. Neuroradiology, 57(10), 991-997.
     
  223. Friedrich B, Gawlitza M, Schob S, Hobohm C, Raviolo M, Hoffmann KT, Lobsien D (2015). Distance to thrombus in acute middle cerebral artery occlusion: a predictor of outcome after intravenous thrombolysis for acute ischemic stroke. Stroke, 46(3), 692-696.
     
  224. Conforto AB, de Freitas GR, Schonewille WJ, Kappelle LJ, Algra A (2015). Prodromal Transient Ischemic Attack or Minor Stroke and Outcome in Basilar Artery Occlusion. J Stroke Cerebrovasc Dis, 24(9), 2117-2121.
     
  225. Fazekas F, Enzinger C, Schmidt R, Grittner U, Giese AK, Hennerici MG, Huber R, Jungehulsing GJ, Kaps M, Kessler C, Martus P, Putaala J, Ropele S, Tanislav C, Tatlisumak T, Thijs V, von Sarnowski B, No (2015). Brain magnetic resonance imaging findings fail to suspect Fabry disease in young patients with an acute cerebrovascular event. Stroke, 46(6), 1548-1553.
     
  226. Thijs V, Grittner U, Dichgans M, Enzinger C, Fazekas F, Giese AK, Kessler C, Kolodny E, Kropp P, Martus P, Norrving B, Ringelstein EB, Rothwell PM, Schmidt R, Tanislav C, Tatlisumak T, von Sarnowski B (2015). Family History in Young Patients With Stroke. Stroke, 46(7), 1975-1978.
     
  227. Compter A, van der Hoeven EJ, van der Worp HB, Vos JA, Weimar C, Rueckert CM, Kappelle LJ, Algra A, Schonewille WJ (2015). Vertebral artery stenosis in the Basilar Artery International Cooperation Study (BASICS): prevalence and outcome. J Neurol, 262(2), 410-417.
     
  228. Pallesen LP, Gerber J, Dzialowski I, van der Hoeven EJ, Michel P, Pfefferkorn T, Ozdoba C, Kappelle LJ, Wiedemann B, Khomenko A, Algra A, Hill MD, von Kummer R, Demchuk AM, Schonewille WJ, Puetz V (2015). Diagnostic and Prognostic Impact of pc-ASPECTS Applied to Perfusion CT in the Basilar Artery International Cooperation Study. J Neuroimaging, 25(3), 384-389.
     
  229. Dankowski T, Buck D, Andlauer TF, Antony G, Bayas A, Bechmann L, Berthele A, Bettecken T, Chan A, Franke A, Gold R, Graetz C, Haas J, Hecker M, Herms S, Infante-Duarte C, Jockel KH, Kieseier BC, Knier (2015). Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array. Genet Epidemiol, 39(8), 601-608.
     
  230. Moller K, Posel C, Kranz A, Schulz I, Scheibe J, Didwischus N, Boltze J, Weise G, Wagner DC (2015). Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke. Front Cell Neurosci, 9, 461.
     
  231. Gluck ME, Alonso-Alonso M, Piaggi P, Weise CM, Jumpertz-von Schwartzenberg R, Reinhardt M, Wassermann EM, Venti CA, Votruba SB, Krakoff J (2015). Neuromodulation targeted to the prefrontal cortex induces changes in energy intake and weight loss in obesity. Obesity (Silver Spring), 23(11), 2149-2156.
     


  232. 2014


  233. Busse K, Strotmann R, Strecker K, Wegner F, Devanathan V, Gohla A, Schoneberg T, Schwarz J (2014). Adaptive gene regulation in the Striatum of RGS9-deficient mice. PLoS One, 9(3), e92605.
     
  234. Hobohm C, Fritzsch D, Budig S, Classen J, Hoffmann KT, Michalski D (2014). Predicting intracerebral hemorrhage by baseline magnetic resonance imaging in stroke patients undergoing systemic thrombolysis. Acta Neurol Scand, 130(5), 338-345.
     
  235. Zeller D, Classen J (2014). Plasticity of the motor system in multiple sclerosis. Review Neuroscience, 283C, 222-230.
     
  236. Stoppe M, Thoma E, Liebert UG, Major EO, Hoffmann KT, Classen J, Then Bergh F (2014). Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis. J Neurol, 261(5), 1021-1024.
     
  237. Viehmann M, Weise D, Brähler E, Reichel G, Classen J, Baum P (2014). Complementary and alternative medicine usage in German cervical dystonia patients Basal ganglia, 4(2), 55-59.
     
  238. Suchan J, Umarova R, Schnell S, Himmelbach M, Weiller C, Karnath HO, Saur D (2014). Fiber pathways connecting cortical areas relevant for spatial orienting and exploration. Hum Brain Mapp, 35(3), 1031-1043.
     
  239. Bechmann L, Busse K, Stoppe M, Cotte S, Ettrich B, Then Bergh F (2014). Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis. J Neuroimmunol, 276(1-2), 159-165.
     
  240. Lobsien D, Ettrich B, Sotiriou K, Classen J, Then Bergh F, Hoffmann KT (2014). Whole-brain diffusion tensor imaging in correlation to visual-evoked potentials in multiple sclerosis: a tract-based spatial statistics analysis. AJNR Am J Neuroradiol, 35(11), 2076-2081.
     
  241. Kumpfel T, Schwan M, Weber F, Holsboer F, Trenkwalder C, Then Bergh F (2014). Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis. Psychoneuroendocrinology, 45, 87-95.
     
  242. Hesse S, Moeller F, Petroff D, Lobsien D, Luthardt J, Regenthal R, Becker GA, Patt M, Thomae E, Seese A, Meyer PM, Bergh FT, Sabri O (2014). Altered serotonin transporter availability in patients with multiple sclerosis. Eur J Nucl Med Mol Imaging, 41(5), 827-835.
     
  243. Lehmann J, Hartig W, Seidel A, Fuldner C, Hobohm C, Grosche J, Krueger M, Michalski D (2014). Inflammatory cell recruitment after experimental thromboembolic stroke in rats. Neuroscience, 279, 139-154.
     
  244. Nowicki M*, Baum P*, Kosacka J*, Stockinger M, Kloting N, Bluher M, Bechmann I, Toyka KV (2014). Effects of isoflurane anesthesia on F-waves in the sciatic nerve of the adult rat. Muscle Nerve, 50(2), 257-261.
     
  245. Weise CM, Hohenadel MG, Krakoff J, Votruba SB (2014). Body composition and energy expenditure predict ad-libitum food and macronutrient intake in humans. Int J Obes (Lond), 38(2), 243-251.
     
  246. Weise G, Lorenz M, Posel C, Maria Riegelsberger U, Storbeck V, Kamprad M, Kranz A, Wagner DC, Boltze J (2014). Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab, 34, 1-9.
     
  247. Wagner DC, Posel C, Schulz I, Schicht G, Boltze J, Lange F, Scheibe J, Moller K, Weise G (2014). Allometric dose retranslation unveiled substantial immunological side effects of granulocyte colony-stimulating factor after stroke. Stroke, 45, 623-626.
     
  248. Vollmann H, Ragert P, Conde V, Villringer A, Classen J, Witte OW, Steele CJ (2014). Instrument specific use-dependent plasticity shapes the anatomical properties of the corpus callosum: a comparison between musicians and non-musicians. Front Behav Neurosci, 8, 245.
     
  249. Fiorio M, Emadi Andani M, Marotta A, Classen J, Tinazzi M (2014). Placebo-induced changes in excitatory and inhibitory corticospinal circuits during motor performance. J Neurosci, 34(11), 3993-4005.
     
  250. Fiorio M, Mariotti C, Panzeri M, Antonello E, Classen J, Tinazzi M (2014). The role of the cerebellum in dynamic changes of the sense of body ownership: a study in patients with cerebellar degeneration. J Cogn Neurosci, 26(4), 712-721.
     
  251. Sehm B, Taubert M, Conde V, Weise D, Classen J, Dukart J, Draganski B, Villringer A, Ragert P (2014). Structural brain plasticity in Parkinsons disease induced by balance training. Neurobiol Aging, 35(1), 232-239.
     
  252. Olbrich S, Trankner A, Chittka T, Hegerl U, Schonknecht P (2014). Functional connectivity in major depression: increased phase synchronization between frontal cortical EEG-source estimates. Psychiatry Res, 222(1-2), 91-99.
     
  253. Muller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, Senderek J, Weis J, Baum P, Deschauer M, Zierz S (2014). Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol, 76(5), 669-680.
     
  254. Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, Deykin A (2014). Pegylated interferon ?-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Lancet Neurol, 13(7), 657-665.
     
  255. Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, Kumpfel T (2014). Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol, 261(1), 1-16.
     
  256. Werner P, Fritzsch D, Holland H, Bauer M, Krupp W, Hoffmann KT, Saur D, Then Bergh F, Sabri O, Barthel H (2014). Definition of primary and secondary glioblastoma-letter. Clin Cancer Res, 20(7), 2011-2012.
     
  257. Hartig W, Saul A, Kacza J, Grosche J, Goldhammer S, Michalski D, Wirths O (2014). Immunolesion-induced loss of cholinergic projection neurones promotes ?-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice. Neuropathol Appl Neurobiol, 40(2), 106-120.
     
  258. Gawlitza M, Fritzsch D, Quaschling U, Hobohm C, Hoffmann KT, Lobsien D (2014). Mechanical thrombectomy in patients with acute vertebrobasilar occlusion using the Trevo device: a single-centre experience. Neuroradiology, 56(11), 977-983.
     
  259. van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, Gluud C, Kollmar R, Krieger DW, Lees KR, Molina C, Montaner J, Roine RO, Petersson J, Staykov D, Szabo I, Wardlaw JM, Sch (2014). EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke. Int J Stroke, 9(5), 642-645.
     
  260. Gawlitza M, Quaschling U, Hobohm C, Otto J, Voigt P, Hoffmann KT, Lobsien D (2014). Hyperintense basilar artery on FLAIR MR imaging: diagnostic accuracy and clinical impact in patients with acute brain stem stroke. AJNR Am J Neuroradiol, 35(8), 1520-1526.
     
  261. Mazya MV, Ahmed N, Ford GA, Hobohm C, Mikulik R, Nunes AP, Wahlgren N (2014). Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register. Stroke, 45(6), 1657-1663.
     
  262. Juttler E, Unterberg A, Woitzik J, Bosel J, Amiri H, Sakowitz OW, Gondan M, Schiller P, Limprecht R, Luntz S, Schneider H, Pinzer T, Hobohm C, Meixensberger J, Hacke W (2014). Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med, 370(12), 1091-1100.
     
  263. Matzke C, Hammer N, Weise D, Lindner D, Fritzsch D, Classen J, Meixensberger J, Winkler D (2014). [Deep brain stimulation using simultaneous stereotactic electrode placement : An alternative to conventional functional stereotaxy?]. Nervenarzt, 85(12), 1561-1568.
     
  264. Kotz SA, Stockert A, Schwartze M (2014). Cerebellum, temporal predictability and the updating of a mental model. Philos Trans R Soc Lond B Biol Sci, 369(1658), 20130403.
     
  265. Posel C, Uri A, Schulz I, Boltze J, Weise G, Wagner DC (2014). Flow cytometric characterization of brain dendritic cell subsets after murine stroke. Exp Transl Stroke Med, 6(1), 11.
     
  266. Reichel JM, Nissel S, Rogel-Salazar G, Mederer A, Kafer K, Bedenk BT, Martens H, Anders R, Grosche J, Michalski D, Hartig W, Wotjak CT (2014). Distinct behavioral consequences of short-term and prolonged GABAergic depletion in prefrontal cortex and dorsal hippocampus. Front Behav Neurosci, 8, 452.
     


  267. 2013


  268. Michalski D, Hartig W, Krugel K, Edwards RH, Boddener M, Bohme L, Pannicke T, Reichenbach A, Grosche A (2013). Region-specific expression of vesicular glutamate and GABA transporters under various ischaemic conditions in mouse forebrain and retina. Neuroscience, 231, 328-44.
     
  269. Krueger M, Hartig W, Reichenbach A, Bechmann I, Michalski D (2013). Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One, 8(2), e56419.
     
  270. Hartig W, Michalski D, Seeger G, Voigt C, Donat CK, Dulin J, Kacza J, Meixensberger J, Arendt T, Schuhmann MU (2013). Impact of 5-lipoxygenase inhibitors on the spatiotemporal distribution of inflammatory cells and neuronal COX-2 expression following experimental traumatic brain injury in rats. Brain Res, 1498, 69-84.
     
  271. Pelz J, Härtig W, Weise C, Hobohm C, Schneider D, Krueger M, Kacza J, Michalski D (2013). Endothelial barrier antigen-immunoreactivity is conversely associated with blood-brain barrier dysfunction after embolic stroke in rats. Eur J Histochem, 57, e38.
     
  272. Rumpf JJ, Weise D, Fricke C, Wetzig T, Simon JC, Classen J (2013). Sonographic abnormality of the substantia nigra in melanoma patients. Mov Disord, 28(2), 219-223.
     
  273. Schabrun SM, Weise D, Ridding MC, Classen J (2013). A new temporal window for inducing depressant associative plasticity in human primary motor cortex. Clin Neurophysiol, 124(6), 1196-1203.
     
  274. Weise D, Mann J, Ridding M, Eskandar K, Huss M, Rumpf JJ, Di Lazzaro V, Mazzone P, Ranieri F, Classen J (2013). Microcircuit mechanisms involved in paired associative stimulation-induced depression of corticospinal excitability. J Physiol, 591(Pt19), 4903-4920.
     
  275. Hartwigsen G, Siebner HR (2013). Novel methods to study aphasia recovery after stroke. Front Neurol Neurosci, 32, 101-111.
     
  276. Kummerer D, Hartwigsen G, Kellmeyer P, Glauche V, Mader I, Kloppel S, Suchan J, Karnath HO, Weiller C, Saur D (2013). Damage to ventral and dorsal language pathways in acute aphasia. Brain, 136(Pt2), 619-629.
     
  277. Kellmeyer P, Ziegler W, Peschke C, Juliane E, Schnell S, Baumgaertner A, Weiller C, Saur D (2013). Fronto-parietal dorsal and ventral pathways in the context of different linguistic manipulations. Brain Lang, 17(2), 241-250.
     
  278. Baum P, Petroff D, Classen J, Kiess W, Bluher S (2013). Dysfunction of autonomic nervous system in childhood obesity: a cross-sectional study. PLoS One, 8(1), e54546.
     
  279. Hartwigsen G, Saur D, Price CJ, Baumgaertner A, Ulmer S, Siebner HR (2013). Increased facilitatory connectivity from the pre-SMA to the left dorsal premotor cortex during pseudoword repetition. J Cogn Neurosci, 25(4), 580-594.
     
  280. Hartwigsen G, Saur D, Price CJ, Ulmer S, Baumgaertner A, Siebner HR (2013). Perturbation of the left inferior frontal gyrus triggers adaptive plasticity in the right homologous area during speech production. Proc Natl Acad Sci U S A, 110(41), 16402-16407.
     
  281. Woost TB, Dukart J, Frisch S, Barthel H, Sabri O, Mueller K, Schroeter ML (2013). Neural correlates of the DemTect in Alzheimer\'s disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study. Neuroimage Clin, 2, 746-758.
     
  282. Weise CM, Thiyyagura P, Reiman EM, Chen K, Krakoff J (2013). Fat-free body mass but not fat mass is associated with reduced gray matter volume of cortical brain regions implicated in autonomic and homeostatic regulation. Neuroimage, 64, 712-721.
     
  283. Reiche M, Hartwigsen G, Widmann A, Saur D, Schroger E, Bendixen A (2013). Involuntary attentional capture by speech and non-speech deviations: A combined behavioral-event-related potential study. Brain Res, 1490, 153-160.
     
  284. Kosacka J, Nowicki M, Bluher M, Baum P, Stockinger M, Toyka KV, Kloting I, Stumvoll M, Serke H, Bechmann I, Kloting N (2013). Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol, 250, 125-135.
     
  285. Kropp P, Holzhausen M, Kolodny E, Becker U, Dichgans M, Diez-Tejedor E, Enzinger C, Fazekas F, Fuentes B, Karpinska A, Meyer W, Tanislav C, Bottcher T, Rolfs A (2013). Headache as a symptom at stroke onset in 4,431 young ischaemic stroke patients. Results from the "Stroke in Young Fabry Patients (SIFAP1) study". J Neural Transm, 120(10), 1433-1440.
     
  286. Fazekas F, Enzinger C, Schmidt R, Dichgans M, Gaertner B, Jungehulsing GJ, Hennerici MG, Heuschmann P, Holzhausen M, Kaps M, Kessler C, Martus P, Putaala J, Ropele S, Tanislav C, Tatlisumak T, Norrvin (2013). MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology, 81(22), 1914-1921.
     
  287. Hawkes CA, Michalski D, Anders R, Nissel S, Grosche J, Bechmann I, Carare RO, Hartig W (2013). Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations. Exp Neurol, 250, 270-281.
     
  288. Witsch J, Galldiks N, Bender A, Kollmar R, Bosel J, Hobohm C, Gunther A, Schirotzek I, Fuchs K, Juttler E (2013). Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol, 260(5), 1367-1374.
     
  289. Rolfs A, Fazekas F, Grittner U, Dichgans M, Martus P, Holzhausen M, Bottcher T, Heuschmann PU, Tatlisumak T, Tanislav C, Jungehulsing GJ, Giese AK, Putaala J, Huber R, Bodechtel U, Lichy C, Enzinger C (2013). Acute cerebrovascular disease in the young: the Stroke in Young Fabry Patients study. Stroke, 44(2), 340-349.
     
  290. Lees KR, Bornstein N, Diener HC, Gorelick PB, Rosenberg G, Shuaib A (2013). Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke. Stroke, 44(3), 580-584.
     
  291. Thaler DE, Ruthazer R, Di Angelantonio E, Di Tullio MR, Donovan JS, Elkind MS, Griffith J, Homma S, Jaigobin C, Mas JL, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Serena J, Weimar C, Kent (2013). Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale. Stroke, 44(3), 675-680.
     
  292. Cramer SC, Abila B, Scott NE, Simeoni M, Enney LA (2013). Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke. Stroke, 44(5), 1337-1342.
     
  293. Neugebauer H, Kollmar R, Niesen WD, Bosel J, Schneider H, Hobohm C, Zweckberger K, Heuschmann PU, Schellinger PD, Juttler E (2013). DEcompressive surgery Plus hypoTHermia for Space-Occupying Stroke (DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review. Int J Stroke, 8(5), 383-387.
     
  294. Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE (2013). An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology, 81(7), 619-625.
     
  295. Sharma N, Classen J, Cohen LG (2013). Neural plasticity and its contribution to functional recovery. Handb Clin Neurol, 110, 3-12.
     
  296. Meinzer M, Beeson PM, Cappa S, Crinion J, Kiran S, Saur D, Parrish T, Crosson B, Thompson CK (2013). Neuroimaging in aphasia treatment research: consensus and practical guidelines for data analysis. Neuroimage, 73, 215-224.
     
  297. Baumgaertner A, Hartwigsen G, Roman Siebner H (2013). Right-hemispheric processing of non-linguistic word features: implications for mapping language recovery after stroke. Hum Brain Mapp, 34, 1293-1305.
     
  298. Conradi S, Malzahn U, Paul F, Quill S, Harms L, Then Bergh F, Ditzenbach A, Georgi T, Heuschmann P, Rosche B (2013). Breastfeeding is associated with lower risk for multiple sclerosis. Mult Scler, 19(5), 553-558.
     
  299. Wagner DC, Scheibe J, Glocke I, Weise G, Deten A, Boltze J, Kranz A (2013). Object-based analysis of astroglial reaction and astrocyte subtype morphology after ischemic brain injury. Acta Neurobiol Exp (Wars), 73(1), 79-87.
     
  300. Classen J (2013). Plasticity. In: Lozano AM, Hallett M, Brain Stimulation: Handbook of Clinical Neurology. (S. 525-534), Oxford: Elsvier Ltd..
     
  301. Sharma N, Classen J, Cohen LG (2013). Neural plasticity and its contribution to functional recovery. In: Barnes MP, Good DC, Neurological Rehabilitation: Handbook of Clinical Neurology. (S. 3-12), Oxford: Elsvier Ltd..
     


  302. 2012


  303. Hartwigsen G, Siebner HR (2012). Probing the involvement of the right hemisphere in language processing with online transcranial magnetic stimulation in healthy volunteers. Review. Aphasiology, 26(9), 1131-1152.
     
  304. Diedrichsen J, Classen J (2012). Stimulating news about modular motor control. Neuron, 76(6), 1043-1045.
     
  305. Zeller D, Dang SY, Weise D, Pizzolato F, Rieckmann P, Toyka KV, Classen J (2012). LTD-like central motor plasticity is not compromised in multiple sclerosis patients. BMC Neurol, 12, 92.
     
  306. Weise D, Weise G, Solymosi L, Classen J (2012). Generalized choreic movement disorder due to bilateral recurrent artery of Heubner infarctions. Basal Ganglia, 2, 153-155.
     
  307. Schneider M, Eichfeld U, Beller A, Baum P, Classen J, Then Bergh F (2012). Myasthenia gravis and thymolipoma: a rare variation of a well-known theme]. Nervenarzt, 83(8), 1035-1038.
     
  308. Önal-Hartmann C, Fiorio M, Zeller D, Gentner R, Pauli P, Classen J (2012). After-training emotional interference may modulate sequence awareness in a serial reaction time task. Exp Brain Res, 219(1), 75-84.
     
  309. Weise D, Gentner R, Zeller D, Nagel A, Reinsberger C, Rumpf JJ, Classen J (2012). Focal hand dystonia: Lack of evidence for abnormality of motor representation at rest. Neurology, 78(2), 122-128.
     
  310. Michalski D, Heindl M, Kacza J, Laignel F, Kuppers-Tiedt L, Schneider D, Grosche J, Boltze J, Lohr M, Hobohm C, Hartig W (2012). Spatio-temporal course of macrophage-like cell accumulation after experimental embolic stroke depending on treatment with tissue plasminogen activator and its combination with hyperbaric oxygenation. Eur J Histochem, 56(2), e14.
     
  311. Michalski D, Weise C, Hobohm C, Kuppers-Tiedt L, Pelz J, Schneider D, Kacza J, Hartig W (2012). Autonomic reactions and peri-interventional alterations in body weight as potential supplementary outcome parameters for thromboembolic stroke in rats. Exp Transl Stroke Med, 4(1), 7.
     
  312. Michalski D, Hobohm C, Weise C, Pelz J, Heindl M, Kamprad M, Kacza J, Hartig W (2012). Interrelations between blood-brain barrier permeability and matrix metalloproteinases are differently affected by tissue plasminogen activator and hyperoxia in a rat model of embolic stroke. Med Gas Res, 2(1), 2.
     
  313. Boltze J, Kleinschnitz C, Reymann KG, Reiser G, Wagner DC, Kranz A, Michalski D (2012). Neurovascular pathophysiology in cerebral ischemia, dementia and the ageing brain - current trends in basic, translational and clinical research Exp Transl Stroke Med, 4(1), 14.
     
  314. Wegner F, Kraft R, Busse K, Hartig W, Ahrens J, Leffler A, Dengler R, Schwarz J (2012). Differentiated human midbrain-derived neural progenitor cells express excitatory strychnine-sensitive glycine receptors containing α2β subunits. PLoS One, 7(5), e36946.
     
  315. Hartwigsen G, Bestmann S, Ward NS, Woerbel S, Mastroeni C, Granert O, Siebner HR (2012). Left dorsal premotor cortex and supramarginal gyrus complement each other during rapid action reprogramming. J Neurosci, 32(46), 16162-16171.
     
  316. Saur D, Hartwigsen G (2012). Neurobiology of language recovery after stroke: lessons from neuroimaging studies. Arch Phys Med Rehabil, 93(1Suppl), 15-25.
     
  317. Lohle M, Hermann A, Glass H, Kempe A, Schwarz SC, Kim JB, Poulet C, Ravens U, Schwarz J, Scholer HR, Storch A (2012). Differentiation Efficiency of Induced Pluripotent Stem Cells Depends on the Number of Reprogramming Factors. Stem Cells, 30(3), 570-9.
     
  318. Vergouwen MD, Algra A, Pfefferkorn T, Weimar C, Rueckert CM, Thijs V, Kappelle LJ, Schonewille WJ; Basilar Artery International Cooperation Study (BASICS) Study Group (2012). Time is brain(stem)in basilar artery occlusion. Stroke, 43(11), 3003-3006.
     
  319. Zajonz D, Langsieb C, Chavdarova L, Kellermann S, Baum P, Wickenhauser C, von Salis-Soglio G, Prietzel T (2012). [Multilocular Paget's disease in IBMPFD syndrome. A case report with 14-year follow-up]. Orthopädie, 41(6), 482-487.
     
  320. Antonucci F, Alpar A, Kacza J, Caleo M, Verderio C, Giani A, Martens H, Chaudhry FA, Allegra M, Grosche J, Michalski D, Erck C, Hoffmann A, Harkany T, Matteoli M, Hartig W (2012). Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks. J Neurosci, 32(6), 1989-2001.
     
  321. Davalos A, Alvarez-Sabin J, Castillo J, Diez-Tejedor E, Ferro J, Martinez-Vila E, Serena J, Segura T, Cruz VT, Masjuan J, Cobo E, Secades JJ (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet, 380(9839), 349-357.
     
  322. Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Moller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A (2012). Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke, 43(9), 2336-2342.
     
  323. Weber R, Weimar C, Wanke I, Moller-Hartmann C, Gizewski ER, Blatchford J, Hermansson K, Demchuk AM, Forsting M, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A (2012). Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy. Stroke, 43(2), 350-355.
     
  324. Greving JP, Schonewille WJ, Wijman CA, Michel P, Kappelle LJ, Algra A (2012). Predicting outcome after acute basilar artery occlusion based on admission characteristics. Neurology, 78(14), 1058-1063.
     
  325. Vergouwen MD, Compter A, Tanne D, Engelter ST, Audebert H, Thijs V, de Freitas G, Algra A, Jaap Kappelle L, Schonewille WJ (2012). Outcomes of basilar artery occlusion in patients aged 75 years or older in the Basilar Artery International Cooperation Study. J Neurol, 259(11), 2341-2346.
     
  326. Volkmann J, Wolters A, Kupsch A, Muller J, Kuhn AA, Schneider GH, Poewe W, Hering S, Eisner W, Muller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Ni (2012). Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol, 11(12), 1029-1038.
     
  327. Rosenow F, Schade-Brittinger C, Burchardi N, Bauer S, Klein KM, Weber Y, Lerche H, Evers S, Kovac S, Hallmeyer-Elgner S, Winkler G, Springub J, Niedhammer M, Roth E, Eisensehr I, Berrouschot J, Arnold (2012). The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy-an open-label, prospective, randomised controlled multicenter study. J Neurol Neurosurg Psychiatry, 83(11), 1093-1098.
     
  328. Wieser MJ, Klupp E, Weyers P, Pauli P, Weise D, Zeller D, Classen J, Muhlberger A (2012). Reduced early visual emotion discrimination as an index of diminished emotion processing in Parkinson's disease? - Evidence from event-related brain potentials. Cortex, 48(9), 1207-1217.
     
  329. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012). Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med, 367(12), 1098-1107.
     
  330. Devonshire V, Havrdova E, Radue EW, O\'Connor P, Zhang-Auberson L, Agoropoulou C, Haring DA, Francis G, Kappos L (2012). Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study. Lancet Neurol, 11(5), 420-428.
     
  331. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Tre (2012). Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation, 9, 14.
     
  332. den Ouden DB, Saur D, Mader W, Schelter B, Lukic S, Wali E, Timmer J, Thompson CK (2012). Network modulation during complex syntactic processing. Neuroimage, 59(1), 815-823.
     
  333. Pechmann A, Delvendahl I, Bergmann TO, Ritter C, Hartwigsen G, Gleich B, Gattinger N, Mall V, Siebner HR (2012). The number of full-sine cycles per pulse influences the efficacy of multicycle transcranial magnetic stimulation. Brain Stimul, 5(2), 148-154.
     
  334. Vry MS, Saur D, Rijntjes M, Umarova R, Kellmeyer P, Schnell S, Glauche V, Hamzei F, Weiller C (2012). Ventral and dorsal fiber systems for imagined and executed movement. Exp Brain Res, 219(2), 203-216.
     
  335. Claßen J, Schnitzler A (2012). Pathophysiologie von Bewegungsstörungen. In: Claßen J, Schnitzler A, Interventionelle Neurophysiologie: Grundlagen und therapeutische Anwendungen. (S. 75-79), Stuttgart: Thieme Verlag.
     
  336. Saur D, Hartwigsen G (2012). Funktionsanpassung im sprachlichen System. In: Karnath HO, Thier HP, Kognitive Neurowissenschaften. (S. 741-749), Heidelberg: Springer.
     


  337. 2011


  338. Weise D, Schramm A, Beck M, Reiners K, Classen J (2011). Loss of topographic specificity of LTD-like plasticity is a trait marker in focal dystonia. Neurobiol Dis, 42(2), 171-176.
     
  339. Zeller D, Dang SY, Stefan K, Biller A, Bartsch A, Saur D, Bendszus M, Rieckmann P, Toyka KV, Classen J (2011). Functional role of ipsilateral motor areas in multiple sclerosis. J Neurol Neurosurg Psychiatry, 82(5), 578-583.
     
  340. Michalski D, Liebig S, Thomae E, Hinz A, Bergh FT (2011). Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model. J Pain Res, 4, e219-225.
     
  341. Michalski D, Hartig W, Schneider D, Hobohm C (2011). Use of normobaric and hyperbaric oxygen in acute focal cerebral ischemia - a preclinical and clinical review. Acta Neurol Scand, 123(2), 85-97.
     
  342. Michalski D, Pelz J, Weise C, Kacza J, Boltze J, Grosche J, Kamprad M, Schneider D, Hobohm C, Hartig W (2011). Early outcome and blood-brain barrier integrity after co-administered thrombolysis and hyperbaric oxygenation in experimental stroke. Exp Transl Stroke Med, 3(1), e5.
     
  343. Zeller D, Gross C, Bartsch A, Johansen-Berg H, Classen J (2011). Ventral premotor cortex may be required for dynamic changes in the feeling of limb ownership: a lesion study. J Neurosci, 31(13), e4852-4857.
     
  344. Fiorio M, Weise D, Onal-Hartmann C, Zeller D, Tinazzi M, Classen J (2011). Impairment of the rubber hand illusion in focal hand dystonia. Brain, 134(Pt5), 1428-1437.
     
  345. Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, Classen J, Cavallari P (2011). Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol, 11, e88.
     
  346. Hobohm C, Laignel F, Kacza J, Kuppers-Tiedt L, Heindl M, Schneider D, Grosche J, Hartig W, Michalski D (2011). Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen. Brain Res, 1417, 115-126.
     
  347. Hobohm C, Michalski D (2011). Der verwirrte Patient. Ein medizinischer Notfall. Ars Medici, 5, 192-194.
     
  348. Kurthen M, Schneider D (2011). Pharmakorefraktärer Status epilepticus. Intensivmedizin up2date, 7(2), 133-145.
     
  349. Schwarz J, Odin P, Buhmann C, Csoti I, Jost W, Wullner U, Storch A (2011). Depression in Parkinson's disease. J Neurol, 258(Suppl2), 336-338.
     
  350. Baum P, Bercker S, Villmann T, Claßen J, Hermann W (2011). [Critical illness myopathy and neuropathy (CRIMYN). Electroneurographic classification]. Nervenarzt, 82(4), 468-473.
     
  351. Polak T, Weise D, Metzger F, Ehlis AC, Langer JB, Schramm A, Fallgatter AJ, Classen J (2011). Vagus nerve somatosensory evoked potentials in Parkinson's disease. J Neurol, 258(12), 2276-2277.
     
  352. Günther P, Villmann T, Hermann W (2011). Event Related Potentials and Cognitive Evaluation in Wilson´s Disease With and Without Neurological Manifestation. J Neurol Sci [Turkish], 28(1), 79-85.
     
  353. Skardelly M, Gaber K, Burdack S, Scheidt F, Hilbig H, Boltze J, Forschler A, Schwarz J, Schwarz S, Meixensberger J, Schuhmann MU (2011). Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury. J Neurotrauma, 28(3), 401-414.
     
  354. Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, Lobsien D, Schwarz J, Sabri O (2011). Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter. J Neurol, 258(1), 19-26.
     
  355. Kuppers-Tiedt L, Manaenko A, Michalski D, Guenther A, Hobohm C, Wagner A, Zhang JH, Schneider D (2011). Combined systemic thrombolysis with alteplase and early hyperbaric oxygen therapy in experimental embolic stroke in rats: relationship to functional outcome and reduction of structural damage. Acta Neurochir Suppl, 111, 167-172.
     
  356. Missitzi J, Gentner R, Geladas N, Politis P, Karandreas N, Classen J, Klissouras V (2011). Plasticity in human motor cortex is in part genetically determined. J Physiol, 589(Pt 2), 297-306.
     
  357. Weber R, Diener HC, Weimar C, collab. (2011). Why do acute ischemic stroke patients with a preceding transient ischemic attack present with less severe strokes? Insights from the German Stroke Study. Eur Neurol, 66(5), 265-270.
     
  358. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC, collab. (2011). Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebrovasc Dis, 32(3), 283-288.
     
  359. Rolfs A, Martus P, Heuschmann PU, Grittner U, Holzhausen M, Tatlisumak T, Bottcher T, Fazekas F, Enzinger C, Ropele S, Schmidt R, Riess O, Norrving B (2011). Protocol and methodology of the Stroke in Young Fabry Patients (sifap1) study: a prospective multicenter European study of 5.024 young stroke patients aged 18-55 years. Cerebrovasc Dis, 31(3), 253-262.
     
  360. Umarova RM, Saur D, Kaller CP, Vry MS, Glauche V, Mader I, Hennig J, Weiller C (2011). Acute visual neglect and extinction: distinct functional state of the visuospatial attention system. Brain, 134(Pt11), 3310-3325.
     
  361. den Ouden DB, Saur D, Mader W, Schelter B, Lukic S, Wali E, Timmer J, Thompson CK (2011). Network modulation during complex syntactic processing. Neuroimage, 59(1), 815-823.
     
  362. Rijntjes M, Hamzei F, Glauche V, Saur D, Weiller C (2011). Activation changes in sensorimotor cortex during improvement due to CIMT in chronic stroke. Restor Neurol Neurosci, 29(5), 299-310.
     
  363. Weiller C, Bormann T, Saur D, Musso M, Rijntjes M (2011). How the ventral pathway got lost: and what its recovery might mean. Brain Lang, 118(1-2), 29-39.
     
  364. Siebler M, Hennerici MG, Schneider D, von Reutern GM, Seitz RJ, Rother J, Witte OW, Hamann G, Junghans U, Villringer A, Fiebach JB (2011). Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial. Stroke, 42(9), 2388-2392.
     
  365. Lammer AB, Beck A, Grummich B, Forschler A, Krugel T, Kahn T, Schneider D, Illes P, Franke H, Krugel U (2011). The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo. PLoS One, 6(5), e19983.
     
  366. Loewenbruck KF, Fuchs B, Hermann A, Brandt M, Werner A, Kirsch M, Schwarz S, Schwarz J, Schiller J, Storch A (2011). Proton MR spectroscopy of neural stem cells: does the proton-NMR peak at 1.28 ppm function as a biomarker for cell type or state? Rejuvenation Res, 14(4), 371-381.
     
  367. Skardelly M, Gaber K, Schwarz J, Milosevic J (2011). Neuroprotective effects of the beta-catenin stabilization in an oxygen- and glucose-deprived human neural progenitor cell culture system. Int J Dev Neurosci, 29(5), 543-547.
     
  368. Schecklmann M, Volberg G, Frank G, Hadersdorfer J, Steffens T, Weisz N, Landgrebe M, Hajak G, Greenlee M, Classen J, Langguth B (2011). Paired associative stimulation of the auditory system: a proof-of-principle study. PLoS One, 6(11), e27088.
     
  369. Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauss M, Baum P, Hegerl U, Schonknecht P (2011). CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Res, 190(2-3), 240-243.
     
  370. Puetz V, Khomenko A, Hill MD, Dzialowski I, Michel P, Weimar C, Wijman CA, Mattle HP, Engelter ST, Muir KW, Pfefferkorn T, Tanne D, Szabo K, Kappelle LJ, Algra A, von Kummer R, Demchuk AM, Schonewille (2011). Extent of hypoattenuation on CT angiography source images in basilar artery occlusion: prognostic value in the Basilar Artery International Cooperation Study. Stroke, 42(12), 3454-3459.
     


  371. 2010


  372. Gunther P, Baum P, Then Bergh F, Hermann W (2010). [Wilson's disease and multiple sclerosis] Nervenarzt, 81(2), 226-228.
     
  373. Schwarz J (2010). "Update" on stem-cell research in Parkinson´s disease. parkinson´s Europe, 1, 6.
     
  374. Thomae E, Niklas A, Sebraouri H, Baum P, Wagner A, Then Bergh F (2010). "Improving Test-Retest Variability of Visual-Evoked Responses in Multiple Sclerosis" J Clin Neurophysiol, 27(4), 270-273.
     
  375. Guenther P, Baum P, Villmann T, Hermann W (2010). EEG-Befunde in der stabilen Therapiephase des Morbus Wilson. Klin Neurophysiol, 41(3), 193-197.
     
  376. Hobohm C, Michalski D (2010). Der verwirrte Patient - ein Notfall? Allgemeinarzt, 16, 34-36.
     
  377. Michalski D, Liebig S, Thomae E, Singer S, Hinz A, Then Bergh F (2010). Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis Mental Illness, 2, e5.
     
  378. Schwarz J (2010). [Nuclear medicine imaging in patients with Parkinson's syndrome: an update]. Nervenarzt, 81(10), 1160-1167.
     
  379. Schwarz J, Storch A (2010). Transplantation in Parkinson's disease: will mesenchymal stem cells help to reenter the clinical arena? Transl Res, 155(2), 55-56.
     
  380. Schwarz SC, Schwarz J (2010). Translation of stem cell therapy for neurological diseases. Transl Res, 156(3), 155-160.
     
  381. Classen J, Nitzsche S, Wallwiener D, Kristen P, Souchon R, Bamberg M, Brucker S (2010). Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients. Strahlenther Onkol, 186(11), 630-636.
     
  382. Gentner R, Gorges S, Weise D, aufm Kampe K, Buttmann M, Classen J (2010). Encoding of motor skill in the corticomuscular system of musicians. Curr Biol, 20(20), 1869-1874.
     
  383. Classen J, Schnitzler A (2010). What does the pedunculopontine nucleus do? Neurology, 75(11), 944-945.
     
  384. Wankerl K, Weise D, Gentner R, Rumpf JJ, Classen J (2010). L-type voltage-gated Ca2+ channels: a single molecular switch for long-term potentiation/long-term depression-like plasticity and activity-dependent metaplasticity in humans. J Neurosci, 30(18), 6197-6204.
     
  385. Zeller D, aufm Kampe K, Biller A, Stefan K, Gentner R, Schutz A, Bartsch A, Bendszus M, Toyka KV, Rieckmann P, Classen J (2010). Rapid-onset central motor plasticity in multiple sclerosis. Neurology, 74(9), 728-735.
     
  386. Hartwigsen G, Siebner HR, Stippich C (2010). Preoperative functional magnetic resonance imaging (fMFRI) and transcranial magnetic stimulation (TMS) Curr Med Imaging Rev, 6(4), 220-231.
     
  387. Hartwigsen G, Baumgaertner A, Price CJ, Koehnke M, Ulmer S, Siebner HR (2010). Phonological decisions require both the left and right supramarginal gyri. Proc Natl Acad Sci U S A, 107(38), 16494-16499.
     
  388. Hartwigsen G, Siebner HR, Deuschl G, Jansen O, Ulmer S (2010). Incidental findings are frequent in young healthy individuals undergoing magnetic resonance imaging in brain research imaging studies: a prospective single-center study. J Comput Assist Tomogr, 34(4), 596-600.
     
  389. Hartwigsen G, Price CJ, Baumgaertner A, Geiss G, Koehnke M, Ulmer S, Siebner HR (2010). The right posterior inferior frontal gyrus contributes to phonological word decisions in the healthy brain: evidence from dual-site TMS. Neuropsychologia, 48(10), 3155-3163.
     
  390. Saur D (2010). [Imaging aphasia]. Nervenarzt, 81(12), 1429-1437.
     
  391. Saur D, Ronneberger O, Kummerer D, Mader I, Weiller C, Kloppel S (2010). Early functional magnetic resonance imaging activations predict language outcome after stroke. Brain, 133(4), 1252-1264.
     
  392. Saur D, Schelter B, Schnell S, Kratochvil D, Kupper H, Kellmeyer P, Kummerer D, Kloppel S, Glauche V, Lange R, Mader W, Feess D, Timmer J, Weiller C (2010). Combining functional and anatomical connectivity reveals brain networks for auditory language comprehension. Neuroimage, 49(4), 3187-3197.
     
  393. Michalski D, Grosche J, Pelz J, Schneider D, Weise C, Bauer U, Kacza J, Gärtner U, Hobohm C, Härtig W (2010). A novel quantification of blood-brain barrier damage and histochemical typing after embolic stroke in rats. Brain Res, 1359, 186-200.
     
  394. Schroeter ML, Ettrich B, Menz M, Zysset S (2010). Traumatic brain injury affects the frontomedian cortex--an event-related fMRI study on evaluative judgments. Neuropsychologia, 48(1), 185-193.
     
  395. Reichmann H, Rau T, Schnittler HJ, Schwarz J, Schweizer S, Weiss N (2010). "Periphere Ödeme beim Parkinson-Syndrom - Die Rolle der Dopaminagonisten" Thieme Drug Report, 4, 1-16.
     
  396. Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, FREEDOM Study Group (2010). A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med, 362(5), 387-401.
     
  397. Schmidt FM, Brugel M, Kratzsch J, Strauss M, Sander C, Baum P, Thiery J, Hegerl U, Schonknecht P (2010). Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neurosci Lett, 483(1), 20-22.
     
  398. Arnold M, Fischer U, Compter A, Gralla J, Findling O, Mattle HP, Kappelle LJ, Tanne D, Algra A, Schonewille WJ (2010). Acute basilar artery occlusion in the Basilar Artery International Cooperation Study: does gender matter? Stroke, 41(11), 2693-2696.
     
  399. Schabitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S, Schneider D, Hamann GF, Rosenkranz M, Veltkamp R, Fiebach JB, Hacke W, Grotta JC, Fisher M, Schneider A (2010). AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke, 41(11), 2545-2551.
     
  400. Thomalla G, Hartmann F, Juettler E, Singer OC, Lehnhardt FG, Kohrmann M, Kersten JF, Krutzelmann A, Humpich MC, Sobesky J, Gerloff C, Villringer A, Fiehler J, Neumann-Haefelin T, Schellinger PD, Rothe (2010). Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study. Ann Neurol, 68(4), 435-445.
     
  401. Weber R, Kraywinkel K, Diener HC, Weimar C (2010). Symptomatic intracranial atherosclerotic stenoses: prevalence and prognosis in patients with acute cerebral ischemia. Cerebrovasc Dis, 30(2), 188-193.
     
  402. Weimar C, Kraywinkel K, Hagemeister C, Haass A, Katsarava Z, Brunner F, Haverkamp C, Schmid E, Diener HC (2010). Recurrent stroke after cervical artery dissection. J Neurol Neurosurg Psychiatry, 81(8), 869-873.
     
  403. Weimar C, Benemann J, Michalski D, Muller M, Luckner K, Katsarava Z, Weber R, Diener HC (2010). Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke, 41(3), 487-493.
     
  404. Dengler R, Diener HC, Schwartz A, Grond M, Schumacher H, Machnig T, Eschenfelder CC, Leonard J, Weissenborn K, Kastrup A, Haberl R (2010). Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol, 9(2), 159-166.
     
  405. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, B (2010). Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet, 375(9727), 1695-1703.
     
  406. Lottaz C, Beier D, Meyer K, Kumar P, Hermann A, Schwarz J, Junker M, Oefner PJ, Bogdahn U, Wischhusen J, Spang R, Storch A, Beier CP (2010). Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res, 70(5), 2030-2040.
     
  407. Maisel M, Habisch HJ, Royer L, Herr A, Milosevic J, Hermann A, Liebau S, Brenner R, Schwarz J, Schroeder M, Storch A (2010). Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. Exp Cell Res, 316(17), 2760-2778.
     
  408. Wolz M, Lohle M, Strecker K, Schwanebeck U, Schneider C, Reichmann H, Grahlert X, Schwarz J, Storch A (2010). Levetiracetam for levodopa-induced dyskinesia in Parkinson\'s disease: a randomized, double-blind, placebo-controlled trial. J Neural Transm, 117(11), 1279-1286.
     
  409. Melzer N, Classen J, Reiners K, Buttmann M (2010). Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090Q. J Neurol Sci, 296(1-2), 104-106.
     
  410. Romanos M, Weise D, Schliesser M, Schecklmann M, Loffler J, Warnke A, Gerlach M, Classen J, Mehler-Wex C (2010). Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder. J Psychiatry Neurosci, 35(1), 55-58.
     
  411. Dressel K, Huber W, Frings L, Kümmerer D, Saur D, Mader i, Hüll M, Weiller C, Abel S (2010). Model-oriented naming therapy in semantic dementia: A single-case fMRI study. Aphasiology, 24(12), 1537 – 1558.
     
  412. Frings L, Dressel K, Abel S, Saur D, Kummerer D, Mader I, Weiller C, Hull M (2010). Reduced precuneus deactivation during object naming in patients with mild cognitive impairment, Alzheimer\'s disease, and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord, 30(4), 334-343.
     
  413. Rusch N, Bracht T, Kreher BW, Schnell S, Glauche V, Il\'yasov KA, Ebert D, Lieb K, Hennig J, Saur D, van Elst LT (2010). Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder. Psychiatry Res, 181(2), 151-154.
     
  414. Ulmer S, Hartwigsen G, Riedel C, Jansen O, Mehdorn HM, Nabavi A (2010). Intraoperative dynamic susceptibility contrast MRI (iDSC-MRI) is as reliable as preoperatively acquired perfusion mapping. Neuroimage, 49(3), 2158-2162.
     
  415. Umarova RM, Saur D, Schnell S, Kaller CP, Vry MS, Glauche V, Rijntjes M, Hennig J, Kiselev V, Weiller C (2010). Structural connectivity for visuospatial attention: significance of ventral pathways. Cereb Cortex, 20(1), 121-129.
     
  416. Ward NS, Bestmann S, Hartwigsen G, Weiss MM, Christensen LO, Frackowiak RS, Rothwell JC, Siebner HR (2010). Low-frequency transcranial magnetic stimulation over left dorsal premotor cortex improves the dynamic control of visuospatially cued actions. J Neurosci, 30(27), 9216-9223.
     
  417. Boessner G, Lackner P, Fischer M, Beer R, Helbok R, Pfausler B, Schneider D, Schmutzhard E (2010). Influence of Prophylactic, Endovascularly Based Normothermia on Inflammation in Patients with Severe Cerebrovascular Disease. A Prospective, Randomized Trail. Stroke, 41(12), 2969-2972.
     
  418. Saur D, Weiller C (2010). Recovery from aphasia: lessons from imaging studies (2010) In: Cramer SC, Nudo RJ (Eds.), Brain Repair after Stroke (S. 125-132), Cambridge, England: Cambridge University Press.
     


  419. 2009


  420. Niklas A, Sebraoui H, Heß E, Wagner A, Then Bergh F (2009). Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency. Multiple Sclerosis, 15(1), 68-74.
     
  421. Michalski D, Kuppers-Tiedt L, Weise C, Laignel F, Hartig W, Raviolo M, Schneider D, Hobohm C (2009). Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats. Brain Res, 1303, 161-168.
     
  422. Classen J, Zeller D, aufm Kampe K, Dang S (2009). Plastizität des motorischen Systems bei Multipler Sklerose Fortschr Neurol Psychiatr, 77, S45-S48.
     
  423. Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J (2009). Substantia nigra echogenicity: A structural correlate of degeneration of dopaminergic projection neurons in Parkinson´s disease Mov Disord, 24, 1669-1675.
     
  424. Kraft P, Waschbisch A, Wendel F, Muellges W, Classen J (2009). Why it´s important to know Percheron´s artery: Solitary carotid stenosis causing anterior, posterior and bithalamic stroke J Neurol, 256(9), 1558-1560.
     
  425. Gentner R, Classen J (2009). Development and evaluation of a low cost sensor glove for assessment of human finger movements in neurophysiological settings J Neurosci Methods, 178(1), 138-147.
     
  426. Kraft P, Gadeholt O, Wieser MJ, Jennings J, Classen J (2009). Lying obliquely - a clinical sign of cognitive impairment: cross sectional observational study. BMJ, 339, 5273 ff.
     
  427. Dieterlen MT, Wegner F, Schwarz SC, Milosevic J, Schneider B, Busch M, Romuss U, Brandt A, Storch A, Schwarz J (2009). Non-viral gene transfer by nucleofection allows stable gene expression in human neural progenitor cells. J Neurosci Methods, 178(1), 15-23.
     
  428. Meyer PM, Strecker K, Kendziorra K, Becker G, Hesse S, Woelpl D, Hensel A, Patt M, Sorger D, Wegner F, Lobsien D, Barthel H, Brust P, Gertz HJ, Sabri O, Schwarz J (2009). Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry, 66(8), 866-877.
     
  429. Milosevic J, Adler I, Manaenko A, Schwarz SC, Walkinshaw G, Arend M, Flippin LA, Storch A, Schwarz J (2009). Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells. Neurotox Res, 15(4), 367-380.
     
  430. Milosevic J, Schwarz SC, Ogunlade V, Meyer AK, Storch A, Schwarz J (2009). Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation. Mol Neurodegener, 4, 25.
     
  431. Schaarschmidt G, Wegner F, Schwarz SC, Schmidt H, Schwarz J (2009). Characterization of voltage-gated potassium channels in human neural progenitor cells. PLoS One, 4(7), e6168.
     
  432. Wegner F, Kraft R, Busse K, Schaarschmidt G, Hartig W, Schwarz SC, Schwarz J (2009). Glutamate receptor properties of human mesencephalic neural progenitor cells: NMDA enhances dopaminergic neurogenesis in vitro. J Neurochem, 111(1), 204-216.
     
  433. Focke A, Schwarz J (2009). Was bringt die nuklearmedizinische Untersuchung bei Parkinsonsyndromen? InFo Neurologie & Psychiatrie, 11(9), 49-51.
     
  434. Baum P, Bercker S, Günther P, Wagner A, Hermann W (2009). Elektromyo- und -neurographische Untersuchungen bei Sepsis-/SIRS-Patienten zur Verlaufsbeurteilung einer Critical Illness Myopathie und Neuropathie (CRIMYN) Akt Neurol, 36(3), 111-116.
     
  435. Günther P, Kuhn HJ, Villmann T, Hermann W (2009). Fine motor skills disorders in the course of Wilson´s disease. Ann Indian Acad Neurol, 12(1), 28-34.
     
  436. Michalski D, Hobohm C, Küppers-Tiedt L, Fritzsch D, Lobsien D (2009). Anhaltende Bewusstseinsstörung als Folge eines Verschlusses der Arterie von Percheron. Akt Neurol, 36(1), 30-32.
     
  437. Michalski D, Zweynert U, Kittel J, Hinz A (2009). Schmerzempfinden und Schmerzverhalten während der orthopädischen Rehabilitation. Schmerz, 23(4), 360-369.
     
  438. Thijs VN, Peeters A, Vosko M, Aichner F, Schellinger PD, Schneider D, Neumann-Haefelin T, Rother J, Davalos A, Wahlgren N, Verhamme P (2009). Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke. Stroke, 40(12), 3789-3795.
     
  439. Khurana D, Kaul S, Bornstein NM (2009). Implant for augmentation of cerebral blood flow trial 1: a pilot study evaluating the safety and effectiveness of the Ischaemic Stroke System for treatment of acute ischaemic stroke. Int J Stroke, 4(6), 480-485.
     
  440. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jahnig P, Herrmann M, Knauth M, Bahr M, Heide W, Wagner A, Schwab S, Reichmann (2009). Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke, 40(12), 3647-3656.
     
  441. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, Kuppers-Tiedt L, Schneider D, Schmutzhard E (2009). Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke, 40(12), 3657-3665.
     
  442. Teal P, Davis S, Hacke W, Kaste M, Lyden PD, Fierus M (2009). A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT). Stroke, 40(11), 3518-3525.
     
  443. Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici MG, Mattle HP, Rothwell PM (2009). Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study. Cerebrovasc Dis, 27(5), 509-518.
     
  444. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke, 40(6), 2244-2250.
     
  445. Zivin JA, Albers GW, Bornstein N, Chippendale T, Dahlof B, Devlin T, Fisher M, Hacke W, Holt W, Ilic S, Kasner S, Lew R, Nash M, Perez J, Rymer M, Schellinger P, Schneider D, Schwab S, Veltkamp R, Wal (2009). Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke, 40(4), 1359-1364.
     
  446. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Sohngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermar (2009). Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol, 8(2), 141-150.
     
  447. Wechsler L, Steindler D, Borlongan C, Chopp M, Savitz S, Deans R, Caplan L, Hess D, Mays RW, Boltze J, Boncoraglio G, Carmichael ST, Davidoff AW, Deans RJ, Fisher M, Kondziolka D, Norving B, Parati E, (2009). Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke, 40(2), 510-515.
     
  448. Chaturvedi S, Zivin J, Breazna A, Amarenco P, Callahan A, Goldstein LB, Hennerici M, Sillesen H, Rudolph A, Welch MA, SPARCL Investigators (2009). Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology, 72(8), 688-694.
     
  449. Quartarone A, Classen J, Morgante F, Rosenkranz K, Hallett M (2009). Consensus paper: Use of transcranial magnetic stimulation to probe motor cortex plasticity in dystonia and levodopa-induced dyskinesia Brain stimulation, 2(2), 108-117.
     
  450. Rossi, Hallett M, Rossini PM, Pascual-Leone A and the The Safety of TMS Consensus Group (2009). Safety, Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research Clin Neurophysiol, 120(12), 2008-2039.
     
  451. Huang YZ, Sommer M, Thickbroom G, Hamada M, Pascuale-Leonne A, Paulus W, Classen J, Peterchev AV, Zangen A, Ugawa Y (2009). Consensus: New methodologies for brain stimulation Brain stimulation, 2(1), 2-13.
     
  452. Bruegel M, Planert M, Baumann S, Focke A, Bergh FT, Leichtle A, Ceglarek U, Thiery J, Fiedler GM (2009). Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Proteomics, 72(4), 608-615.
     
  453. Enard W, Gehre S, Hammerschmidt K, ... Bruckner MK, ..., Arendt T, de Angelis MH, Fischer J, Schwarz J, Pääbo S (2009). A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell, 137(5), 961-971.
     
  454. Freudenberg U, Hermann A, Welzel PB, Stirl K, Schwarz SC, Grimmer M, Zieris A, Panyanuwat W, Zschoche S, Meinhold D, Storch A, Werner C (2009). A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. Biomaterials, 30(28), 5049-5060.
     
  455. Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, Cubo E, Martinez-Martin P, Rascol O, Negre-Pages L, Senard A, Schwarz J, Strecker K, Reichmann H, Storch A, Lohle M, Stocchi F, Grosset K (2009). Adherence to antiparkinson medication in a multicenter European study. Mov Disord, 24(6), 826-832.
     
  456. Hermann A, Suess C, Fauser M, Kanzler S, Witt M, Fabel K, Schwarz J, Hoglinger GU, Storch A (2009). Rostro-caudal gradual loss of cellular diversity within the periventricular regions of the ventricular system. Stem Cells, 27(4), 928-941.
     
  457. Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, Sabri O (2009). Monoamine transporter availability in Parkinson\'s disease patients with or without depression. Eur J Nucl Med Mol Imaging, 36(3), 428-435.
     
  458. Kraft E, Loichinger W, Diepers M, Lule D, Schwarz J, Ludolph AC, Storch A (2009). Levodopa-induced striatal activation in Parkinson\'s disease: a functional MRI study. Parkinsonism Relat Disord, 15(8), 558-563.
     
  459. Rubini P, Milosevic J, Engelhardt J, Al-Khrasani M, Franke H, Heinrich A, Sperlagh B, Schwarz SC, Schwarz J, Norenberg W, Illes P (2009). Increase of intracellular Ca2+ by adenine and uracil nucleotides in human midbrain-derived neuronal progenitor cells. Cell Calcium, 45(5), 485-498.
     
  460. Sabolek M, Baumann B, Heinrich M, Meyer AK, Herborg A, Liebau S, Maisel M, Hermann A, Ventz K, Schwarz J, Wirth T, Storch A (2009). Initiation of dopaminergic differentiation of Nurr1(-) mesencephalic precursor cells depends on activation of multiple mitogen-activated protein kinase pathways. Stem Cells, 27(8), 2009-2021.
     
  461. Schaarschmidt G, Schewtschik S, Kraft R, Wegner F, Eilers J, Schwarz J, Schmidt H (2009). A new culturing strategy improves functional neuronal development of human neural progenitor cells. J Neurochem, 109(1), 238-247.
     
  462. O'Brien JT, McKeith IG, Walker Z, Tatsch K, Booij J, Darcourt J, Marquardt M, Reininger C (2009). Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry, 194(1), 34-39.
     
  463. Häuser W, Grulke N, Michalski D, Hoffmann A, Akritidou I, Klauenberg S, Maier C, Hinz A (2009). Intensität von Gliederschmerzen und Erschöpfung bei Fibromyalgiesyndrom, depressiven Störungen und chronischen Rückenschmerzen. Ein Unterscheidungskriterium. Schmerz, 23(3), 267-274.
     
  464. Zweynert U, Michalski D, Kittel J, Hinz A (2009). Gesundheitsbezogene Lebensqualität bei Patienten der orthopädischen Rehabilitation Phys Rehab Kur Med, 19(3), 133-141.
     
  465. Hinz A, Krauss O, Stolzenburg JU, Schwalenberg T, Michalski D, Schwarz R (2009). Anxiety and depression in patients with prostate cancer and other urogenital cancer: a longitudinal study. Urol Oncol, 27(4), 367-372.
     
  466. Schonewille WJ, Wijman CA, Michel P, Rueckert CM, Weimar C, Mattle HP, Engelter ST, Tanne D, Muir KW, Molina CA, Thijs V, Audebert H, Pfefferkorn T, Szabo K, Lindsberg PJ, de Freitas G, Kappelle LJ, A (2009). Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol, 8(8), 724-730.
     
  467. Weimar C, Benemann J, Huber R, Mieck T, Kaendler S, Grieshammer S, Katsarava Z, Diener HC (2009). Long-term mortality and risk of stroke after transient ischemic attack: a hospital-based cohort study. J Neurol, 256(4), 639-644.
     
  468. Weimar C, Holle DN, Benemann J, Schmid E, Schminke U, Haberl RL, Diener HC, Goertler M (2009). Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis, 28(4), 349-356.
     
  469. Weber R, Goertler M, Benemann J, Diener HC, Weimar C (2009). Prognosis after cryptogenic cerebral ischemia in patients with coagulopathies. Cerebrovasc Dis, 28(6), 611-617.
     


  470. 2008


  471. Wegner F, Deuther-Conrad W, Scheunemann M, Brust P, Fischer S, Hiller A, Diekers M, Strecker K, Wohlfarth K, Allgaier C, Steinbach J, Hoepping A (2008). GABA(A) receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon. Eur J Pharmacol, 580(1-2), 1-11.
     
  472. Hesse S, Barthel H, Strecker K, Oehlwein C, Sabri O, Schwarz J (2008). Radionuclide Imaging in Patients with Parkinsonian Syndrome Akt Neurol, 35(8), 389-398.
     
  473. Schwarz J, Storch A (2008). Regenerative Therapie des Morbus Parkinson - Zusammenfassung. Parkinson Nachrichten, 105, 9-10.
     
  474. Wagner A, Steinberg H (2008). Hans Steinert (1875-1911). J Neurol, 255(10), 1607-1608.
     
  475. Steinberg H, Wagner A (2008). Hans Steinert: Zum 100. Jahrestag der Erstbeschreibung der myotonen Dystrophie. Nervenarzt, 79(8), 961-970.
     
  476. Focke A, Schwarz S, Foerschler A, Scheibe J, Milosevic J, Zimmer C, Schwarz J (2008). Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med, 60(6), 1321-1328.
     
  477. Kimmel S, Pfeiffer D, Schwarz J (2008). [Syncope. A diagnostic challenge.] Internist (Berl), 49(2), 185-198.
     
  478. Schwarz J, Gratz S, Hahn U, Forstl H, Jarnig M (2008). [The status of imaging methods for the treatment of patients with Parkinson's syndrome] Dtsch Med Wochenschr, 133 (Suppl 1), 8-10.
     
  479. Strecker K, Meixensberger J, Schwarz J, Winkler D (2008). Increase of frequency in deep brain stimulation relieves apraxia of eyelid opening in patients with Parkinson's disease: case report. Neurosurgery, 63(6), E1204.
     
  480. Strecker K, Schwarz J (2008). Parkinson's disease: emerging pharmacotherapy. Expert Opin Emerg Drugs, 13(4), 573-591.
     
  481. Wegner F, Kraft R, Busse K, Hartig W, Schaarschmidt G, Schwarz SC, Schwarz J, Hevers W (2008). Functional and molecular analysis of GABA receptors in human midbrain-derived neural progenitor cells. J Neurochem, 107(4), 1056-1069.
     
  482. Wegner F, Strecker K, Boeckler D, Wagner A, Preul Ch, Lobsien D, Sabri O, Hesse S (2008). Intact serotonergic and dopaminergic systems in two cases of orthostatic tremor. J Neurol, 255(11), 1840-1842.
     
  483. Michalski D, Zweynert U, Kuppers-Tiedt L, Hinz A (2008). [Physical complaints, emotional stress and locus of control in the course of orthopaedic rehabilitation] Rehabilitation (Stuttg), 47(5), 299-307.
     
  484. Hesse S, Strecker K, Winkler D, Luthardt J, Scherfler C, Reupert A, Oehlwein C, Barthel H, Schneider JP, Wegner F, Meyer P, Meixensberger J, Sabri O, Schwarz J (2008). Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up. J Neurol, 255(7), 1059-1066.
     
  485. Hoepping A, Diekers M, Deuther-Conrad W, Scheunemann M, Fischer S, Hiller A, Wegner F, Steinbach J, Brust P (2008). Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors. Bioorg Med Chem, 16(3), 1184-1194.
     
  486. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 359(13), 1317-1329.
     
  487. Hahn U, Schwarz J, Gratz S, Kaiser JW, Jarnig M, Forstl H (2008). [Morphological magnetic resonance imaging: its value for the diagnosis of neurodegenerative diseases] Dtsch Med Wochenschr, 133 (Suppl 1), S15-18.
     
  488. Haag A, Knake S, Hamer HM, Boesebeck F, Freitag H, Schulz R, Baum P, Helmstaedter C, Wellmer J, Urbach H, Hopp P, Mayer T, Hufnagel A, Jokeit H, Lerche H, Uttner I, Meencke HJ, Meierkord H, Pauli E, R (2008). The Wada test in Autrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures Epilepsy & Behavior, 13(1), 83-89.
     
  489. Forstl H, Gratz S, Hahn U, Schwarz J, Jarnig M (2008). [Dementia with Lewy bodies and reduced dopamine transporter binding indicates significant acetylcholine deficiency] Dtsch Med Wochenschr, 133 (Suppl 1), S11-14.
     
  490. Gratz S, Hahn U, Kaiser JW, Jarnig M, Schwarz J, Forstl H (2008). [Nuclear medicine imaging in neurodegenerative dementias] Dtsch Med Wochenschr, 133 (Suppl 1), S5-7.
     
  491. Bachhuber A, Wagner A, Reichel F, Doberenz M, Stenner A, Hermann W (2008). Nachweis von Botulinum-Toxin-Antikörper - Korrelation des Extensor-digitorum-brevis-Test mit dem Mouse Diaphragma Bioassay Nervenarzt, 79(8), 908-911.
     
  492. Diener HC, Schneider D, Lampl Y, Bornstein NM, Kozak A, Rosenberg G (2008). DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Stroke, 39(6), 1774-1778.
     
  493. Sabolek M, Mieskes I, Lenk T, Lehmensiek V, Hermann A, Schwarz J, Storch A (2008). Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. Neurotoxicology, 29(4), 714-721.
     
  494. Martinez-Torres F, Menon S, Pritsch M, Victor N, Jenetzky E, Jensen K, Schielke E, Schmutzhard E, de Gans J, Chung CH, Luntz S, Hacke W, Meyding-Lamade U (2008). Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]. BMC Neurol, 8, 40.
     
  495. Leinweber B, Moller JC, Scherag A, Reuner U, Gunther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H (2008). Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease. Mov Disord, 23(1), 54-62.
     
  496. Sacco RL, Diener HC, Yusuf S, Cotton D, Ôunpuu S et al - PRoFESS Study Group (2008). Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke N Engl J Med, 359, 1238-1251.
     
  497. Mayer SA, Nikolai CB, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, for FAST Trial Investigators (2008). Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage N Engl J Med, 358, 2127-2137.
     
  498. Jost W, Berg D, Braune S, Dodel R, Gasser T, Gerlach M, Greulich W, Herting B, Kalbe E, Kassubek J, Kessler J, Lemke MR, Reichmann H, Schwarz J, Unrath A (2008). Kapitel 6.3 PET und SPECT in der Differenzialdiagnose von Patienten mit Parkinsonsyndrom. In: Jost W, Diagnostik des Parkinsonsyndroms. (S. 79-84), Bremen: UNI-MED Verlag.
     
  499. Kurthen M, Janzen RWC, Lerche H, Schmidt D, Schneider D, Stefan H, Steinhoff B, Trinka E (2008). Status epilepticus im Erwachsenenalter. In: Diener HC, Putzki N, Leitlinien für Diagnostik und Therapie in der Neurologie. (S. 17-27), Stuttgart, New York: Georg Thieme Verlag.
     
  500. Müllges W, Brenneisen C, Meixensberger J, Reinert M, Schneider D, Toyka KV (2008). Hirndruck. In: Diener HC, Putzki N, Leitlinien für Diagnostik und Therapie in der Neurologie. (S. 868-877), Stuttgart, New York: Georg Thieme Verlag.
     


  501. 2007


  502. Wegner F, Strecker K, Schwarz J, Wagner A, Heinritz W, Sommerer F, Thal DR, Schneider JP, Kendziorra K, Sabri O (2007). Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system. J Neurol, 254(12), 1743-1745.
     
  503. Hermann W, Günther P, Kuhn HJ, Villmann T, Wagner A (2007). Computergestützte Analyse der Handschrift bei Patienten mit Morbus Wilson. Klin Neurophysiol, 38(3), 185-189.
     
  504. Wegner F, Rassler C, Allgaier C, Strecker K, Wohlfarth K (2007). Auto-modulation of neuroactive steroids on GABA A receptors: a novel pharmacological effect. Neuropharmacology, 52(2), 672-683.
     
  505. Gunther P, Hermann W, Kuhn HJ, Wagner A (2007). [Wilson's disease] Ther Umsch, 64(1), 57-61.
     
  506. Strecker K, Hesse S, Wegner F, Sabri O, Schwarz J, Schneider JP (2007). Eye of the Tiger sign in multiple system atrophy. Eur J Neurol, 14(11), e1-e2.
     
  507. Strecker K, Schneider JP, Sabri O, Wegner F, Then Bergh F, Schwarz J, Hesse S (2007). Responsiveness to a dopamine agent in Holmes tremor - case report. Eur J Neurol, 14(4), e9-e10.
     
  508. Then Bergh F (2007). The clock keeps ticking for intravenous methylprednisolone. J Neurol Neurosurg Psychiatry, 78(8), 788-.
     
  509. Then Bergh F, Kumpfel T, Yassouridis A, Lechner C, Holsboer F, Trenkwalder C (2007). Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clin Endocrinol (Oxf), 66(2), 295-303.
     
  510. Milosevic J, Maisel M, Wegner F, Leuchtenberger J, Wenger RH, Gerlach M, Storch A, Schwarz J (2007). Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. J Neurosci, 27(2), 412-421.
     
  511. Milosevic J, Schwarz SC, Maisel M, Poppe-Wagner M, Dieterlen MT, Storch A, Schwarz J (2007). Dopamine D2/D3 receptor stimulation fails to promote dopaminergic neurogenesis of murine and human midbrain-derived neural precursor cells in vitro. Stem Cells Dev, 16(4), 625-635.
     
  512. Hermann W, Günther P, Kühn HJ, Villmann T, Bachhuber A, Wagner A (2007). Pyramidale Schädigung im Vergleich zur extrapyramidalmotorischen Beeinträchtigung bei Patienten mit Morbus Wilson. Klin Neurophysiol, 38(4), 216-221.
     
  513. Hermann W, Günther P, Kühn HJ, Schneider JP, Eichelkraut S, Villmann T, Strecker K, Schwarz J, Wagner A (2007). FAEP und Morphometrie des Mesenzephalons bei Morbus Wilson. Aktuel Neurol, 34(10), 547-554.
     
  514. Wagner A, Hermann W, Hesse S, Sabri O, Wagner A (2007). Einfluss der repetitiven transkraniellen Magnetstimulation (rTMS) auf motorische Störungen bei Patienten mit Morbus Parkinson und Morbus Wilson Klin Neurophysiol, 38(3), 169-178.
     
  515. Günther P, Hermann W, Kühn HJ, Schneider JP, Wagner A (2007). Karotisdissektion unter langjähriger D-Penizillamin-Therapie bei Morbus Wilson J Neurol Neurochir Psychiatr, 8(4), 40-41.
     
  516. Müller C, Baum P, Wagner A (2007). Wertigkeit quantitativer EMG-Parameter bezogen auf die Kraftentwicklung von Muskeln bei Patienten mit Amyotropher Lateralsklerose Klin Neurophysiol, 38(4), 236-240.
     
  517. Baum P, Kopf A, Hermann W, Wagner A (2007). Postiktale paranoid-halluzinatorische Psychose bei kryptogener Epilepsie Psychiat Prax, 34(5), 249-252.
     
  518. Schwarz J, Storch A (2007). Medikamenten-induzierte Psychose bei Patienten mit Morbus Parkinson Neurotransmitter, 18(4), 59-63.
     
  519. Schwarz J (2007). Developmental perspectives on human midbrain-derived neural stem cells. Parkinsonism Relat Dis, 13(Suppl 2), S466-S468.
     
  520. Schwarz J, Arnold G, Csoti I, Fogel W, Oechsner M, Urban P, Walter U, Storch A (2007). Progressive supranukleäre Paralyse (PSP) Aktuel Neurol, 34(S1), 25-27.
     
  521. Hinz A, Michalski D, Schwarz R, Herzberg PY (2007). The acquiescence effect in responding to a questionnaire. GMS Psycho-Social-Medicine, 4, 1-11.
     
  522. Odemis V, Boosmann K, Dieterlen MT, Engele J (2007). The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta}. J Cell Sci, 120(22), 4050-4059.
     
  523. Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, Gold SM (2007). Stress regulation in multiple sclerosis: current issues and concepts. Mult Scler, 13(2), 143-148.
     
  524. Hoepping A, Scheunemann M, Fischer S, Deuther-Conrad W, Hiller A, Wegner F, Diekers M, Steinbach J, Brust P (2007). Radiosynthesis and biological evaluation of an 18F-labeled derivative of the novel pyrazolopyrimidine sedative-hypnotic agent indiplon. Nucl Med Biol, 34(5), 559-570.
     
  525. Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ, Poewe W (2007). Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord, 22(9), 1229-1238.
     
  526. Maisel M, Herr A, Milosevic J, Hermann A, Habisch HJ, Schwarz S, Kirsch M, Antoniadis G, Brenner R, Hallmeyer-Elgner S, Lerche H, Schwarz J, Storch A (2007). Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells, 25(5), 1231-1240.
     
  527. Wirkner K, Gunther A, Weber M, Guzman SJ, Krause T, Fuchs J, Koles L, Norenberg W, Illes P (2007). Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cereb Cortex, 17(3), 621-631.
     
  528. Winkler D, Strauss G, Helm J, Goldammer A, Schneider JP, Schwarz J, Meixensberger J (2007). MicroTargeting® platform: an individual stereotaxic device in functional neurosurgery Int J CARS, 1(5), 295-299.
     
  529. Woldag H, Gerhold LL, de Groot M, Wohlfahrt K, Wagner A, Hummelsheim H (2007). Frühe Prädiktoren für das Rehabilitationsergebnis bei Patienten nach ischämischem Schlaganfall Neurologie & Rehabilitation , 13(4), 201-206.
     
  530. McKeith I, O'Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, Padovani A, Giubbini R, Bonuccelli U, Volterrani D, Holmes C, Kemp P, Tabet N, Meyer I, Reininger C (2007). Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol, 6(4), 305-313.
     


  531. 2006


  532. Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, Wagner A, Al-Ali HK (2006). Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis. Acta Haematol, 116(3), 207-210.
     
  533. Milosevic J, Brandt A, Roemuss U, Arnold A, Wegner F, Schwarz SC, Storch A, Zimmermann H, Schwarz J (2006). Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling. J Neurochem, 99(3), 913-923.
     
  534. Schwarz J, Schwarz SC, Storch A (2006). Developmental perspectives on human midbrain-derived neural stem cells. Neurodegener Dis, 3, 45-49.
     
  535. Storch A, Hwang YI, Bringmann G, Feineis D, Ott S, Bruckner R, Schwarz J (2006). Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells. J Neural Transm, 113(12), 1895-1901.
     
  536. Schwarz J, Schwarz SC, Dorigo O, Stutzer A, Wegner F, Labarca C, Deshpande P, Gil JS, Berk AJ, Lester HA (2006). Enhanced expression of hypersensitive alpha4* nAChR in adult mice increases the loss of midbrain dopaminergic neurons. FASEB J, 20(7), 935-946.
     
  537. Strecker K, Schneider JP, Barthel H, Hermann W, Wegner F, Wagner A, Schwarz J, Sabri O, Zimmer C (2006). Profound midbrain atrophy in patients with Wilson's disease and neurological symptoms? J Neurol, 253(8), 1024-1029.
     
  538. Schwarz J, Heimhilger E, Storch A (2006). Increased periodontal pathology in Parkinson's disease. J Neurol, 253(5), 608-611.
     
  539. Milosevic J, Juch F, Storch A, Schwarz J (2006). Low extracellular calcium is sufficient for survival and proliferation of murine mesencephalic neural precursor cells. Cell Tissue Res, 324(3), 377-384.
     
  540. Schneider JP, Reinohs M, Prothmann S, Puccini S, Dalitz B, Schwarz J, Zimmer C, Then Bergh F (2006). Subcortical Right Parietal AVM Rotational vertigo and caloric stimulation fMRI support a parietal representation of vestibular input. J Neurol, 253(2), 253-255.
     
  541. Boeckler D, Baum P, Wagner A (2006). Elektrophysiologisches Monitoring bei akuter hyperkaliämischer Tetraparese. Klin Neurophysiol, 37(3), 194-197.
     
  542. Baum P, Schober R, Müller, C, Wagner A (2006). EMG-Veränderungen bei Myoadenylatdeaminasemangel (MMAD) Klin Neurophysiol, 37(2), 144-150.
     
  543. Lammer A, Gunther A, Beck A, Krugel U, Kittner H, Schneider D, Illes P, Franke H (2006). Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci, 23(10), 2824-2828.
     
  544. Then Bergh F, Kumpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismuller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP (2006). Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol, 6, 19.
     
  545. Schneider D (2006). Zerebrale Ischämie. MedReport, 9, 6.
     
  546. Schwarz SC, Wittlinger J, Schober R, Storch A, Schwarz J (2006). Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A. Parkinsonism Relat Disord, 12(5), 302-308.
     
  547. Wagner A (2006). Nachruf für Prof. Dr. med. habil. Peter Feudell Ärzteblatt Sachsen, 17(11), 575.
     
  548. Hanitzsch R, Kuppers-Tiedt L (2006). The complexity of the afterpotential of rabbit A-type horizontal cells. Vis Neurosci, 23(6), 871-877.
     
  549. Sabolek M, Herborg A, Schwarz J, Storch A (2006). Dexamethasone blocks astroglial differentiation from neural precursor cells. Neuroreport, 17(16), 1719-1723.
     
  550. Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T (2006). Psychosis pathways converge via D2high dopamine receptors. Synapse, 60(4), 319-346.
     
  551. Hermann A, Maisel M, Liebau S, Gerlach M, Kleger A, Schwarz J, Kim KS, Antoniadis G, Lerche H, Storch A (2006). Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem, 98(2), 629-640.
     
  552. Hermann A, Liebau S, Gastl R, Fickert S, Habisch HJ, Fiedler J, Schwarz J, Brenner R, Storch A (2006). Comparative analysis of neuroectodermal differentiation capacity of human bone marrow stromal cells using various conversion protocols. J Neurosci Res, 83(8), 1502-1514.
     
  553. Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, Sabri O (2006). Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm, 113(9), 1177-1190.
     
  554. Lehmensiek V, Tan EM, Liebau S, Lenk T, Zettlmeisl H, Schwarz J, Storch A (2006). Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Neurochem Int, 48(5), 329-340.
     
  555. Hermann A, Maisel M, Wegner F, Liebau S, Kim DW, Gerlach M, Schwarz J, Kim KS, Storch A (2006). Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells, 24(4), 949-964.
     
  556. Diener HC, Ringelstein EB, von Kummer R, Landgraf H, Koppenhagen K, Harenberg J, Rektor I, Csanyi A, Schneider D, Klingelhofer J, Brom J, Weidinger G (2006). Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the PROTECT Trial. Stroke, 37(1), 139-144.
     
  557. Henninger N, Kuppers-Tiedt L, Sicard KM, Gunther A, Schneider D, Schwab S (2006). Neuroprotective effect of hyperbaric oxygen therapy monitored by MR-imaging after embolic stroke in rats. Exp Neurol, 201(2), 316-323.
     
  558. Schneider JP, Krohmer S, Gunther A, Zimmer C (2006). [Cerebral lesions in acute arterial hypertension: the characteristic MRI in hypertensive encephalopathy] Rofo, 178(6), 618-626.
     
  559. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, Skolnick BE, Davis SM (2006). Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery, 59(4), 767-73.
     
  560. Garcia de Arriba S, Wegner F, Gruner K, Verdaguer E, Pallas M, Camins A, Wagner A, Wohlfahrt K, Allgaier C (2006). Different capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons. Neurochem Int, 49(5), 466-474.
     
  561. Woldag H, Gerhold LL, de Groot M, Wohlfarth K, Wagner A, Hummelsheim H (2006). Early prediction of functional outcome after stroke. Brain Inj, 20(10), 1047-1052.
     
  562. Merkenschlager A, Herbertz S, Baum P, Deschauer M, Syrbe S, Bernhard MK (2006). \"Erhöhte Leberwerte\" - nicht immer Indikatoren gestörter Leberfunktion. Kinder- und Jugendmedizin, 6(6), 366-368.
     
  563. Winkler D, Strauss G, Schwarz J, Meixensberger J (2006). Deutschlandpremiere in der funktionellen Neurochirurgie. Management und Krankenhaus, 5, 10.
     
  564. Nowak K, Lange-Dohna C, Zeitschel U, Gunther A, Luscher B, Robitzki A, Perez-Polo R, Rossner S (2006). The transcription factor Yin Yang 1 is an activator of BACE1 expression. J Neurochem, 96(6), 1696-1707.
     


  565. 2005


  566. Gunther A, Kuppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, Rossner S (2005). Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci, 21(11), 3189-3194.
     
  567. Hobohm C, Gunther A, Grosche J, Rossner S, Schneider D, Bruckner G (2005). Decomposition and long-lasting downregulation of extracellular matrix in perineuronal nets induced by focal cerebral ischemia in rats. J Neurosci Res, 80(4), 539-548.
     
  568. Hermann W, Wagner A, Kuhn HJ, Grahmann F, Villmann T (2005). Classification of fine-motoric disturbances in Wilson's disease using artificial neural networks. Acta Neurol Scand, 111(6), 400-406.
     
  569. Hermann W, Gunther P, Wagner A, Villmann T (2005). [Classification of Wilson's disease based on neurophysiological parameters.] Nervenarzt, 76(6), 733-739.
     
  570. Storch A, Kornhass M, Schwarz J (2005). Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients. J Neurol, 252(1), 84-90.
     
  571. Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J (2005). High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Parkinsonism Relat Disord, 11(6), 393-398.
     
  572. Milosevic J, Schwarz SC, Krohn K, Poppe M, Storch A, Schwarz J (2005). Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors. J Neurochem, 92(4), 718-729.
     
  573. Milosevic J, Storch A, Schwarz J (2005). Cryopreservation does not affect proliferation and multipotency of murine neural precursor cells. Stem Cells, 23(5), 681-688.
     
  574. Kovoor A, Seyffarth P, Ebert J, Barghshoon S, Chen CK, Schwarz S, Axelrod JD, Cheyette BN, Simon MI, Lester HA, Schwarz J (2005). D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci, 25(8), 2157-2165.
     
  575. Arnold G, Gasser T, Storch A, Lipp A, Kupsch A, Hundemer HP, Schwarz J (2005). High doses of pergolide improve clinical global impression in advanced Parkinson's disease:- a preliminary open label study. Arch Gerontol Geriatr, 41(3), 239-253.
     
  576. Schwarz J, Storch A (2005). Zellersatztherapie beim Morbus Parkinson Nervenheilkunde, 24, 36-40.
     
  577. Schwarz J (2005). Unterschiedliche Rezeptorprofile der Dopamin-Agonisten und klinische Auswirkungen Aktuelle Neurologie, 32(S 3), 88-93.
     
  578. Schwarz M, Baas H, Ebersbach G, Jorg J, Kuhn W, Rieke J, Schnitzler A, Schwarz J (2005). Formen und Ausprägungen von Spätkomplikationen Aktuelle Neurologie, 32(S 3), 102-105.
     
  579. Gunther P, Hermann W (2005). Posterior leukoencephalopathy syndrome in patients on cyclosporine A treatment following allogenic hematopoetic stem cell transplantation. J Neurol Sci (Turkish), 22/1, 51-56.
     
  580. Günther P, Villmann T, Wagner A, Hermann W (2005). Motorisch evozierte Potentiale in der Verlaufsdiagnostik des Morbus Wilson Klin Neurophysiol, 36(3), 125-129.
     
  581. Günther P, Minden K, Hermann W, Schneider JP, Wagner A (2005). Tumour necrosis factor receptor-associated periodic syndrome A rare differential diagnosis of multiple sclerosis. Nervenarzt, 76(10), 1263-1266.
     
  582. Schwarz J, Schwarz SC, Storch A (2005). The Role of Neural Stem Cells for Neuroregeneration and Neurorestauration. Int J Neuroprot Neuroreg, 2(1), 27-29.
     
  583. Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, Dujardin M, Grosset DG, Arnold G, Leenders KL, Hundemer HP, Lledo A, Wood A, Frewer P, Schwarz J (2005). Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord, 21(3), 343-353.
     
  584. Heinritz W, Kotzot D, Heinze S, Kujat A, Kleemann WJ, Froster UG (2005). Molecular and cytogenetic characterization of a non-mosaic isodicentric Y chromosome in a patient with Klinefelter syndrome. Am J Med Genet A, 132(2), 198-201.
     
  585. Blatz R, Kuhn HJ, Hermann W, Rytter M, Rodloff AC (2005). [Neurosyphilis and neuroborreliosis Retrospective evaluation of 22 cases.] Nervenarzt, 76(6), 724-732.
     
  586. Winkler D, Tittgemeyer M, Schwarz J, Preul C, Strecker K, Meixensberger J (2005). The first evaluation of brain shift during functional neurosurgery by deformation field analysis. J Neurol Neurosurg Psychiatry, 76(8), 1161-1163.
     
  587. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB (2005). Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage, 24(2), 591-595.
     
  588. Wirkner K, Kofalvi A, Fischer W, Gunther A, Franke H, Groger-Arndt H, Norenberg W, Madarasz E, Vizi ES, Schneider D, Sperlagh B, Illes P (2005). Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J Neurochem, 95(5), 1421-1437.
     
  589. Handschuh R, Haslbeck M, Hartmann A, Fellgiebel A, Kolominsky-Rabas P, Schneider D, Berrouschot J, Erbguth F, Reulbach U (2005). Mortality prediction in critical care for acute stroke: Severity of illness-score or comascale? J Neurol, 252(10), 1249-1254.
     
  590. Winkler D, Schwarz J, Helm J, Reupert A, Preul C, Tittgemeyer M, Schneider JP, Meixensberger J (2005). Tiefenstimulation zur Behandlung des idiopathischen Morbus Parkinson. Ärzteblatt Sachsen, 16(12), 587-590.
     
  591. Boltze J, Kowalski I, Geiger K, Reich D, Gunther A, Bührle Ch, Egger D, Kamprad M, Emmrich F (2005). [Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells.] GMS - German Medical Science, 10, 1-15.
     
  592. Strauss G, Trantakis C, Nowatius E, Falk V, Maass H, Cakmak K, Strauss E, Dietz A, Meixensberger J, Bootz F, Kuhnapfel U (2005). [Virtual training in head- and neurosurgery] Laryngorhinootologie, 84(5), 335-344.
     
  593. Schneider D, Schwab S, Hacke W (2005). Kontroversen in der Neurointensivmedizin. In: Schneider D, Schwab S, Hacke W, Kontroversen in der Neurointensivmedizin. (S. 1-116), Stuttgart: Thieme Verlag.
     


  594. 2004


  595. Storch A, Ludolph AC, Schwarz J (2004). Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm, 111(10-11), 1267-1286.
     
  596. Storch A, Sabolek M, Milosevic J, Schwarz SC, Schwarz J (2004). Midbrain-derived neural stem cells: from basic science to therapeutic approaches. Cell Tissue Res, 318(1), 15-22.
     
  597. Gunther A, Manaenko A, Franke H, Wagner A, Schneider D, Berrouschot J, Reinhardt R (2004). Hyperbaric and normobaric reoxygenation of hypoxic rat brain slices--impact on purine nucleotides and cell viability. Neurochem Int, 45(8), 1125-1132.
     
  598. Gunther A, Schneider JP, Schneider D, Wagner A (2004). [Sinus vein thrombosis.] Fortschr Neurol Psychiatr, 72(11), 652-660.
     
  599. Gunther P, Storch A, Schwarz J, Sabri O, Steinbach P, Wagner A, Hesse S (2004). Basal ganglia involvement of a patient with SCA 17--a new form of autosomal dominant spinocerebellar ataxia. J Neurol, 251(7), 896-897.
     
  600. Milosevic J, Storch A, Schwarz J (2004). Spontaneous apoptosis in murine free-floating neurospheres. Exp Cell Res, 294(1), 9-17.
     
  601. Muller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J (2004). Is levodopa toxic? J Neurol; Suppl. 6, 251, 44-46.
     
  602. Niklas A, Brock D, Schober R, Schulz A, Schneider D (2004). Continuous measurements of cerebral tissue oxygen pressure during hyperbaric oxygenation--HBO effects on brain edema and necrosis after severe brain trauma in rabbits. J Neurol Sci, 219, 77-82.
     
  603. Orb S, Wieacker J, Labarca C, Fonck C, Lester HA, Schwarz J (2004). Knockin mice with Leu9'Ser alpha4-nicotinic receptors: substantia nigra dopaminergic neurons are hypersensitive to agonist and lost postnatally. Physiol Genomics, 18(3), 299-307.
     
  604. Popperl G, Tatsch K, Ruzicka E, Storch A, Gasser T, Schwarz J (2004). Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT. J Neural Transm, 111(8), 1041-1052.
     
  605. Schwarz J, Storch A, Koch W, Pogarell O, Radau PE, Tatsch K (2004). Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline. J Nucl Med, 45(10), 1694-1697.
     
  606. Storch A, Hwang YI, Gearhart DA, Beach JW, Neafsey EJ, Collins MA, Schwarz J (2004). Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake. J Neurochem, 89(3), 685-694.
     
  607. Günther P, Kopf A (2004). Hashimoto-Enzephalopathie Psychiat Prax, 31(6), 310-312.
     
  608. Then Bergh F, Dayyani F, Ziegler-Heitbrock L (2004). Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta. J Neuroimmunol, 146(1-2), 176-188.
     
  609. Deuther-Conrad W, Patt JT, Feuerbach D, Wegner F, Brust P, Steinbach J (2004). Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro. Farmaco, 59(10), 785-792.
     
  610. Franke H, Gunther A, Grosche J, Schmidt R, Rossner S, Reinhardt R, Faber-Zuschratter H, Schneider D, Illes P (2004). P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol, 63(7), 686-699.
     
  611. Hermann A, Gastl R, Liebau S, Popa MO, Fiedler J, Boehm BO, Maisel M, Lerche H, Schwarz J, Brenner R, Storch A (2004). Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci, 117, 4411-4422.
     
  612. Hermann A, Gerlach M, Schwarz J, Storch A (2004). Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration. Expert Opin Biol Ther, 4(2), 131-143.
     
  613. Hesse S, Barthel H, Schwarz J, Sabri O, Muller U (2004). Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev, 28(6), 547-563.
     
  614. Schrodl D, Kahlenberg F, Peter-Zimmer K, Hermann W, Kuhn HJ, Mothes T (2004). Intrathecal synthesis of autoantibodies against tissue transglutaminase. J Autoimmun, 22(4), 335-340.
     
  615. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA (2004). Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science, 306(5698), 1029-1032.
     
  616. Wirkner K, Gerevich Z, Krause T, Gunther A, Koles L, Schneider D, Norenberg W, Illes P (2004). Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons. Neuropharmacology, 46(7), 994-1007.
     
  617. Däuper J, de Groot M, Wiegand K, Guergueltcheva V, Schubert M, Kossev A, Rollnik J D (2004). Repetitive transkranielle Magnetstimulation (rTMS) bei Patienten mit zervikaler Dystonie Klin Neurophysiol, 35(2), 80-84.
     
  618. Richter A, Günther A, Prothmann S, Hermann W, Wagner A, Zimmer C (2004). MRT-Bildgebung eines Patienten mit Wernicke- Enzephalopathie und klinisch stummer zentraler pontiner Myelinolyse Klinische Neuroradiologie, 14(4), 265-268.